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The history of antibiotics 
 2000 B.C. – Here, eat this root  
 1000 A.D. – That root is heathen. Here, say this prayer.  
 1850 A.D. – That prayer is superstition. Here, drink this potion.  
 1920 A.D. – That potion is snake oil. Here, swallow this pill.  
 1945 A.D. – That pill is ineffective. Here, take this penicillin.  
 1955 A.D. – Oops....bugs mutated. Here, take this tetracycline.  
 1960-1999 – 39 more "oops"...Here, take this more powerful antibiotic.  
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1.1 Enterococcus  
1.1.1 Taxonomy:  
Enterococci are Gram positive bacteria occurring as single cocci or in chains. They are lactic 
acid producers and many also produce bacteriocin. Enterococci are non-spore forming, 
facultative anaerobic organisms, catalase negative and have a remarkable ability to withstand 
extreme environments which includes high pH, temperature and salt concentrations (75,164). 
In addition they are relatively resistant to chemical disinfectants such as chlorine, 
gluteraldehyde and alcohol. These qualities are important for survival and spread in the 
hospital environment (28,80,127).  
In 1899 Thiercelin first described the name “entérocoque” referring to its intestinal origin and 
its spherical shape (214). However the enterococci were until 1984 subgrouped into different 
streptococcus groups. The name was revised when Streptococcus faecalis and Streptococcus 
faecium was transferred from the genus Streptococcus to Enterococcus due to new molecular 
information (121,132). The enterococci share phylogenetic relationship with the streptococci. 
Both genera are also related to the Lactococcus sp (103). The phylogenetic relationship 
between enterococci is showed in Figure 1.  
 
According to List of Prokaryotic names with Standing in Nomenclature (LPSN) there are at 
least 40 species included in the Enterococcus genus 
(http://www.bacterio.cict.fr/e/enterococcus.html. 2010.25.02). The two most clinical relevant 
species are the Enterococcus faecium and Enterococcus faecalis which cause the major part of 
human enterococcal infections (228). 





Figure 1. Phylogenetic tree showing the relationships among atpA sequences from different enterococcal 
strains. Bootstrap values after 1,000 repetitions are indicated. Reprinted from (172) with permission from 
the publisher. 
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Enterococci are part of the normal intestinal flora in birds, humans, and animals.  They can 
also colonize the oral cavity and vagina in humans (131). In addition these bacteria are found 
in the soil, on plants, surface water, and other environments exposed to human or animal 
faeces (75,136). In the last two decades enterococci have gained increased awareness as 
important nosocomial pathogens. The main enterococcal infections include urinary tract 
infections, infections in the intra-abdominal cavity, and endocarditis (24).  
1.1.3 Clinical significance  
The majority of clinical enterococcal infections are, as mentioned, caused by E. faecalis and 
E. faecium. E. faecalis is considered more virulent however, E. faecium is more likely to be 
resistant to antibiotics, even those of last resort (241). Twenty years ago only 10% of the 
nosocomial enterococcal infections was caused by E. faecium (241). Now around 40% of the 
enterococcal nosocomial infections worldwide are caused by E. faecium (145,228). This ratio 
started to change in favour of E. faecium in the US during the late 1990s and in Europe 
around the year 2000 (130,162,218,219).  In the last two decades the emergence of 
enterococci as an important nosocomial pathogen has been increasingly documented 
(140,188). The relative proportions of E. faecalis and E. faecium in Norwegian blood culture 




The pathogenesis of enterococcal infections is only partly understood. However, several 
adhesins, hemolysin, hyaluronidase, aggregation substances, gelatinase, and genes encoding 
pili are now considered possible virulence factors (75,79,108,110,199). So far, at least 22 
different genes, collectively called fms (E. faecium surface protein-encoding genes) are 
considered putative virulence factors in E. faecium (202). Virulence factors encoded by acmfm 
(fms8), hyl, espfm, sgrA and ecbA, are most strongly associated with clinical lineages in E. 
faecium (23,45,81,110,171,204).  
Putative E. faecium virulence genes and products, their epidemiology and potential role in 
pathogenesis are listed in Table 1. Resistance in enterococci has increasingly become a 
problem. This issue will be discussed in section 1.3. 
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Table 1.  Overview of putative virulence genes in E. faecium, their virulence and epidemiology 
Virulence gene Pathophysiology/Virulence Epidemiology References 
Esp Biofilm formation 
Pathogenesis of rat endocarditis 
Pathogenesis of mouse urinary 
tract infections 
Antigenic in humans during 
endocarditis and bacteremia 
Specifically linked to 
hospital-associated 
Enterococcus faecium  




General Meeting of the 
American Society of 
Microbiology, Posters 






Binding to collagen type I, IV 
Pathogenesis of rat endocarditis 
Antigenic in humans during 
endocarditis 
Widespread among 










Predicted to be involved in pilus 
biogenesis. 
Widespread among clinical 






Binding to collagen type V and 
to a lesser extent binding to 
collagen type I and fibrinogen. 
Widespread among Efm (203) 
EcbA (orf2430) MSCRAMM  
Binding to collagen type V 
Binding to fibrinogen 




Hyl Not known (putative glycoside 
hydrolase) 
Promotes colonization of mouse 
gastrointestinal tract 
Specifically linked to 













efaAfm Cell wall adhesisn High incidence in clinical 
strains 
(67)  
SgrA (orf2351) MSCRAMM 
Binding to nidogen and 
fibrinogen. May play a role in 
biofilm formation 
High incidence in clinical 
strains 
(110) 
1MSCRAMM – microbial surface component recognizing adhesive matrix molecules  
2CWAP - cell wall-anchored proteins  
3HA – hospital adapted. Table modified from (199) with permission from the publisher 
 
1.1.4 Population structure and global dissemination  
The spread of hospital adapted clonal complexes of E. faecium is considered the major cause 
for the spread of vancomycin resistant enterococci (VRE) globally (240). These lineages are 
most often resistant to ampicillin and ciprofloxacin, and contain a large transferable genomic 
island (140,229,235) and genes for certain virulence markers such as enterococcal surface 
protein (encoded by esp) and a putative glycoside hydrolase (encoded by hylEfm) is often 
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present (82,130). Adhesion to extracellular matrix proteins and formation of biofilms on 
medical devices such as catheters and stents are important properties of enterococci and add 
up to their pathogenicity (239). It seems that the enrichment of virulence genes may have 
added to the success of E. faecium and opened for newer hospital adapted clones (202). The 
clonal complexes have most likely evolved as a result of multiple recombination events rather 
than mutations and possibly stress-inducing conditions in the hospitals favouring selection of 
these clones (13,240). By subsequent acquirement of transposons containing the vancomycin 
resistance clusters vanA or vanB these VRE have become a basis of pandemic potential (240). 
Until recently, all E. faecium clonal complexes were considered to have a common ancestor 
and they all clustered into a single common clonal complex, CC17 (Figure 2). However it 
may seem that this single complex in fact are several hospital adapted clonal complexes that 
have distinct founders (e.g. ST17, ST18, ST22 and ST78 and more) and has developed 
independently in the same niche. The sequence-types ST17, ST18 and ST78 seem to be the 
predominant CC17-genotypes worldwide containing vanA and vanB 
(22,23,45,93,128,130,133,134,140,145,149,181,207,216,225,236,240). E. faecium of animal 
origin has been considered host specific and not particularly related to human lineages. 
However, ampicillin resistant E. faecium belonging to the CC17-genogroup has recently been 
isolated from pigs and dogs (20,56,57,60) indicating that the hospital lineages are not 
restricted to the hospital environment anymore. Putative virulence genes were also detected in 
isolates from dogs (57) The development of these hospital adapted lineages appears to be 
largely associated with horizontal gene transfer and the ability to readily acquire resistance 
genes and virulence determinants (85). In addition a higher number of accessory plasmids, 
such as Inc18 and pRUM, linked to vancomycin resistance, have been detected in CC17-
related strains (106,195). A study performed on isolates of E. faecium from US hospital 
patients at different time periods clearly indicates that the evolution of successful hospital 
adapted clones have been linked to successive horizontal gene transfer of virulence markers 








Figure 2. E. faecium Clonal Complex 17 genotype, shown in circle, is the common way of classifying the 
typical VRE in hospital outbreaks.  Reprinted from (57) with permission from the publisher.  
1.1.5 The E. faecium genome 
The recent developments in pyrosequencing techniques have created a new era for extensive 
sequencing and characterization of the gene collection of bacterial isolates. The technology 
allows thorough analysis of diversity and population structure of clinically important bacteria 
such as E. faecium (228,238).  In 2000 the first draft genome sequence of E. faecium DO was 
published (77) but the whole genome sequence for this strain has not been finished yet and 
there is still sequences missing (228). Recently genome sequencing of fifteen E. faecium has 
been performed due to the new technology (179,229). A study of the sequences of seven 
additional E. faecium from various sources revealed that there is a large difference in the 
genome size between the strains and a variable number of large plasmids present (229). Data 
showed that hospital strains were multi resistant whereas the commensal strains were not. The 
resistance genes appeared to be mostly located on plasmids and up to 30% of the E. faecium 
genome indicated to be non-core (228). Phylogenetic analysis revealed a relative small 
evolutionary distance between six of the seven strains. However there were considerable 
differences in gene content indicating both gene gain and loss as contributors in the evolution 
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proteins in the infectious strains and none in the non-infectious. Seven of these proteins were 
IS elements which may contribute to the genome flexibility in E. faecium. Presence of the 
known virulence genes esp, hyl, and acm were present in clinical strains however not in all. 
The esp gene was verified to be located on a large transferable putative pathogenicity island 
(PAI) indicating that the gene is acquired by horizontal gene transfer (HGT). Comparative 
genomic hybridization studies have also showed that the majority of E. faecium strains of 
clinical origin could be grouped into specific phylogenetic groups (a hospital clade) related to 
the Clonal Complex 17-genogroup. However a variable content of MGE between isolates 
shows that MGE may be important factors contributing to different phenotypic characteristics 
between CC17-related strains. Genes for IS elements and transposases were shown to be more 
enriched in the clinical isolates (228,229).  
 
1.2 Streptococcus  
Streptococci are commensal bacteria on the mucus membranes of the upper respiratory tract, 
gastrointestinal tract, genitourinary tract and the skin (103). The streptococci tend to be more 
susceptible to antibiotics than the enterococci. Streptococci are often classified into three 
main groups in their ability to haemolyse erythrocytes on a blood agar plate; the beta-
haemolytic group, the non-beta haemolytic streptococci and the nutritionally variant 
streptococci, two of them are highlighted in Figure 3 (163). The beta-haemolytic streptococci 
are divided into several subgroups based on differences in specific carbohydrate antigens  - 
group A (contains Streptococcus pyogenes) (GAS), group B (Streptococcus agalacticae) 
(GBS), group C (includes Streptococcus dysgalacticae, Streptococcus equi, Streptococcus 
zooepidemicus, and Streptococcus constellatus) (GCS), and group G (contains Streptococcus 
equisimilis) (GGS) are the most common ones. In addition there are group E, F, P, U and V 
(72). The non-beta haemolytic streptococci include Streptococcus pneumoniae, Streptococcus 
bovis, Streptococcus lutetiensis, and the viridans streptococci. Most of these belong to 
antigenic group D (72). The phylogenetic relationship between Streptococcus species are 
shown in Figure 3. This thesis will focus only on the S. lutetiensis (Group D Streptococcus) 
(163). Normally the streptococci are susceptible for vancomycin. S. lutetiensis has been found 
both in animals and isolated from clinical isolates (72,183). In 1996 a S. lutetiensis isolate was 
shown to hold an approximately 100 kb genomic element containing a vancomycin resistance 
gene cluster highly homologous to the prototype vanB of E. faecalis V583.  




Figure 3. The phylogenetic relationship among 55 Streptococcus species and the classification of different 
streptococcal strains based on 16S rRNA sequences. One exception in this group is S. dysgalacticae subsp. 
dysgalacticae which is not beta-haemolytic but is included for taxonomical reasons. Reprinted from  (72) 
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1.3 Antimicrobial resistance 
The impact of antimicrobial resistant bacteria in terms of cost, morbidity and mortality is 
increasing worldwide (21,46,88). In this regard it is of importance to reveal factors and 
mechanisms which are involved in the evolution and spread of such bacteria. Enterococci are 
considered difficult-to-treat pathogens with inherent clinical resistance to all cephalosporins 
and sulphonamides as well as low-level resistances to aminoglycosides, lincosamides and 
trimethoprim. In addition E. faecium have the unique capacity of acquiring high-level 
resistance to aminoglycosides, ampicillin and vancomycin, the most efficient anti-
enterococcal drugs (5,164). Being part of the gastrointestinal flora the enterococci are in a 
unique situation to receive resistance genes from other commensals, but also transfer these to 
other and more pathogenic bacteria located in the gastrointestinal tract (70,233). This 
emphasizes the clinical importance of enterococci as a reservoir for antimicrobial resistance 
determinants.  
1.3.1 Development of antimicrobial resistance  
An antibiotic is defined as a substance having a biological, semi synthetic or synthetic origin 
which shows selective activity against bacteria and may thus be used in treatment of bacterial 
infections. Antimicrobial susceptibility testing of a clinical isolate is usually based on 
Minimum Inhibitory Concentration (MIC). The MIC value is the lowest concentration of 
antimicrobial agent which inhibits the growth of the bacteria. Clinical MIC breakpoints are 
designed to guide therapy and do not necessarily distinguish between bacteria with and 
without resistance mechanisms. Thus, epidemiological cut off values (the highest MIC value 
of the wild-type population) are designed to detect low level resistance mechanisms and 
monitor resistance development. The clinical MIC breakpoints generally divide bacteria into 
three categories of susceptibility: susceptible, intermediate, or resistant (123). A clinical 
resistant microorganism is unlikely to respond to even maximum doses of a given antibiotic 
(71). Antibiotic resistance was described early after the introduction of the first “real” 
antibiotic – penicillin (147). Later on, this has been the general pattern of observations. 
Within few years after introduction of new antibiotics in clinical practice, resistance tend to 
emerge (157). 
The major part of antibiotics used today and the resistance-genes that gives rise of the 
resistance in several human pathogens have originated from the environment, especially from 
the soil, and have existed for a long time in nature. For example genes for penicillin resistance 
(beta-lactamases) have been estimated to have evolved about 2 billion years ago and genes for 
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vancomycin resistance more than 200 million years ago (231,245). Antibiotic resistance in 
human pathogens is primarily derived from mutation or horizontal gene transfer (4). The 
major driving force has been the selective pressure of antibiotics use, in medical therapy, 
veterinary practice, agriculture and animal farming. However some bacteria do contain 
intrinsic resistance or reduced susceptibility to some antibiotics. Often these genes coding for 
resistance may have as a role to inhibit growth of bacterial competitors in the soil (157,231). 
The species responsible for infections are not producers of antibiotics themselves (157).  
1.3.2 Biochemical mechanisms for antimicrobial resistance  
The biochemical mechanisms of resistance are divided into four classes where the bacteria 
can utilize one or more of these in their defence against antimicrobial agents: i) inactivation/ 
modification of the antimicrobial target which includes degradation and/or chemical 
modification, ii) reduced access due to altered penetration and or efflux that actively get rid of 
the antimicrobial agent before it reaches its target site, iii) altered target or protection of target 
site in which the antibacterial agent can not bind, iv) metabolic bypass by overproduction or 
alternative pathway. 
Antimicrobial resistance in enterococci can be divided into two classes; intrinsic and acquired 
resistance. 
1.3.3 Intrinsic antimicrobial resistance in enterococci 
Intrinsic resistance is due to the lack of target sites for the antibiotic in question or insufficient 
access of the target site within the cell. This resistance is an intrinsic property encoded by the 
host chromosome and is a species-related trait (4,217).  
 Enterococcus is generally considered naturally resistant to cephalosporins due to their low 
affinity for enterococcal penicillin binding proteins (PBPs). The level of susceptibility other 
β-lactam drugs varies between enterococcal species (217). In addition, enterococci express  
resistance to sulphonamides due to their ability to use environmental folate (98,164). Low 
level resistance of aminoglycosides is due to low uptake of the drugs, and resistance to 
lincosamides is due to putative efflux mechanisms (14,166,217). E. gallinarum and E. 
casseliflavus are in addition intrinsically resistant to low levels of vancomycin due to 
production of D-Ala–D-Ser ending peptidoglycan side chain precursors for which 
vancomycin has a lower binding affinity compared to the normal D-Ala-D-Ala side chains 
(131,217).  
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1.3.4 Acquired antimicrobial resistance in enterococci 
There are two ways for a bacterium to acquire resistance to antibacterial agents, either through 
chromosomal mutations or by horizontal gene transfer (HGT), where HGT is considered the 
major mechanism for spread of antimicrobial resistance (59,196). 
 
The intrinsic resistance to several commonly used antibiotics may have given enterococci an 
advantage for acquiring new resistance phenotypes (162). High levels of resistance to 
penicillins associated with β-lactamase activity have been reported in E. faecalis, but is 
considered to be rare (9). Resistance to ampicillin is most often due to modifications in the 
expression of or mutations in essential PBP proteins. Resistance to ampicillin is often seen in 
E. faecium but occurs rarely in E. faecalis (131). Resistance to high levels of aminoglycosides 
(e. g. gentamicin, streptomycin and kanamycin) is due to three mechanisms: reduced uptake 
(due to increased efflux and/or decreased cell permeability), alterations at the ribosomal 
binding sites, or production of aminoglycoside modifying enzymes. Streptomycin resistance 
is acquired mainly via ribosomal resistance by mutations of the 16S or 23S ribosome or 
enzymatic modification by aminoglycoside adenylyl transferases (ANT) of the antibiotic. 
High-level resistance to kanamycin and gentamicin is obtained by aminoclycoside modifying 
enzymes such as phosphotransferases (APH) and adenyltransferases (AAC). The most 
common found in enterocooci are the bifunctional enzyme AAC(6´)-Ie-APH(2´´)-Ic which 
give resistance to most aminoglycosides except streptomycin. The ermB gene is the major 
contributor to the development of resistance to macrolides, lincosamides, and streptogramins. 
The gene encode a methylase modifying an adenosine residue in the bacterial 23S rRNA. A 
plasmid encoded chloramphenicol acetyltransferase gene, cat, has been shown in 20-42% of 
enterococci. Resistance to tetracycline is encoded by tetM and tetN genes among others and is 
seen in up to 80% of enterococci. Resistance is due to production of a protein interacting with 
ribosomes in such a way that the ribosome is protected and unaffected by the antibiotic. High-
level quinolone resistance is gained trough mutations in the subunit for gyrase (GyrA) and in 
the ParC subunit of topoisomerase IV. Enterococci are now also commonly resistant to 
quinolones (8,131). 
1.3.5 Glycopeptide/vancomycin resistance in Enterococcus – GRE/VRE 
The first reports of vancomycin resistant enterococci (VRE) appeared in 1987 in France (142) 
and the United Kingdom (224). In 1989 North America reported their first incidence. Within 
few years New York experienced several major outbreaks of VRE in hospitals (83). Within 
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two decades VRE became the third- to fourth-most important hospital-acquired pathogen 
(234).  
 
The epidemiology of VRE infections is somewhat different in Europe and the US. In Europe 
VRE are often isolated from domestic animals due to the use of avoparcin, an antimicrobial 
drug used in husbandry giving co-resistance to vancomycin in the enterococcal flora of the 
farmers. Avoparcin was forbidden in 1997 however vancomycin resistance genes continuing 
to persist in the environment function as a source for VRE in the community (24,240). In the 
US avoparcin was not used. Still, transmission of VRE and nosocomial infections has been 
more frequent due to higher use of vancomycin in the hospitals (24).  
 
The emergence of glycopeptide resistant enterococci has become a major problem because it 
leaves few options for treatment.  The vancomycin resistance genes are transferable to other 
species, including S. aureus, and selection pressure for the VRE may give rapid expansion of 
resistant populations. In addition, once the problem with VRE has established it is difficult to 
limit (162). Despite the global problem it is important to emphasize that vancomycin 
resistance is not the only challenge we are facing; the enterococci are increasingly acquiring 
resistance to macrolides, amphenicols, fluoroquinolones, aminoglycosides, and even new 
antibiotics such as oritavancin have been selected   (8,14,95,144).  
1.3.6 Glycopeptide resistance mode of action 
The peptidoglycan layer of Gram positive bacteria consist of sugar derivatives which are 
cross linked and a group of amino acids. The peptidoglycan is multilayered where the sugars 
are connected by crosslinking. In E. faecalis  and E. faecium the crosslink consist of two 
alanine molecules; D-Ala – D-Ala which serve as targets of glycopeptides (47) (Figure 4). 
Binding of vancomycin to the D-Ala-D-Ala inhibit two steps in the formation of the new cell 
wall. It inhibits the addition of new sugar derivatives and the interaction interferes with cross-
linking of the peptidoglycan chains to each other. Consequently, the strength of the cell wall 
is weakened and the bacteria are now likely to lyse. 




Figure 4; Resistance to glycopeptides caused by 
the replacement of D-Ala peptidoglycan 
precursor with a D-Lac precursor makes the 
glycopeptide unable to bind to the cell wall. 
Reprinted from (9) with the permission from 
NEJM.  
(Copyright © [2009] Massachusetts Medical 













Glycopeptide resistance is currently divided into nine different classes (vanA, vanB, vanC, 
vanD, vanE, vanG, vanL,  vanM, and vanN) (106,246) (Table 2). The most prevalent acquired 
gene clusters are the vanA and vanB. 
 
vanA is the most common form of acquired glycopeptide resistance found among the 
enterococci. This is also the only type detected in S. aureus so far (47). It is characterized by 
resistance to high levels of both vancomycin and teicoplanin and is often plasmid mediated. It 
is carried on transposon Tn1546 or closely related elements (200).  
vanB type of resistance is associated with inducible variable levels of resistance to 
vancomycin and susceptibility to teicoplanin. The vanB genotypes can be divided into three 
subgroups; vanB1-B3 due to sequence diversity (53). The vanB operon can be located 
chromosomally or on plasmids and is transferable. The vanB cluster consists of seven van 
genes mostly as part of a larger conjugative element (185). 
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Table 2. Vancomycin resistance in clinical relevant bacteria caused by acquired van-type gene clusters. Adapted and modified from (106) with permission from 
publisher. 
Resistance AQUIRED INTRINSIC 
level: High Variable Moderate Low  Low 
Type: VanA VanB VanD VanE VanG VanL VanM VanN VanC 
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Ph.D Thesis, 2010  Bjørkeng, EK. 
 18
The vanB genotype has mainly been seen in hospital outbreaks in Scandinavia and Australia. 
(16,17,93,104,218,237). The vanB2 subtype seems to be the dominant vanB genotype in most 
studies. This dominance is presumably related to its integral location in the conjugative 
transposon Tn5382-like (51,55,61,100,150-152,159,164,223,234). 
 
1.4 Gene transfer mechanisms and their contributions to the development 
of antimicrobial resistance in enterococci   
1.4.1 Mechanisms 
 Transfer of genes in bacteria is performed in two ways; vertical and horizontal gene transfer.  
Vertical gene transfer is genes inherited from parent cells to their offspring. All successful 
antibiotics targets single gene products encoding essential, functions in the bacteria. A 
mutation which only slightly changes the protein to which the antibiotic is directed may well 
make the organism resistant to that drug. These bacteria will persist in an environment 
containing the actual antibiotic. However in an environment where exposure to lethal levels of 
antibiotics is not continuous it is not likely that a single mutation leading to the resistance 
would become an epidemic problem (210). One exception to this notion seems to be the 
acquisition of stable high-level fluoroquinolone resistance which is associated with mutations 
in chromosomal genes involved in DNA-replication. Thus, the acquisition of new DNA by 
horizontal gene transfer have a relative higher impact on the development of antimicrobial 
resistance compared to mutations.  
 
 Horizontal gene transfer (HGT). Horizontal gene transfer (HGT) is the process of which an 
organism take up genetic material from a different organism which is not an offspring of that 
particular organism. This way of acquiring new genetic material has had a great impact on the 
evolution and genome plasticity of prokaryotic organisms, and is the reason for a great extent 
of the spread of resistance genes (180,193,206).   
Resistance genes can be transferred not only within related species but across major 
taxonomic bacterial divisions. The genetic information may be transferred intercellular in 
three major ways; transduction, transformation and conjugation. Not all bacteria are able to 
perform all three processes, but several free living bacteria is able to use at least two of them 
(210). Integration of a foreign element is often limited by defence mechanisms exerted by the 
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recipient (111,156,173) so gene transfer is only successful if the element is able to replicate in 
the host by itself or through insertion in the host genome, expressed and an advantage for the 
recipient. 
 
Transduction. Transduction is a process carried out by temperate bacteriophages which insert 
into the bacterial chromosome as a prophage. This prophage replicates and may at low 
frequency pack the host DNA or some of the host DNA with its own into the new prophage. 
When the cell lyses the bacteriophage may infect a new cell and the new prophage DNA 
integrates into the new recipient chromosome. Normally a transduction is only successful in 
transferring alleles of homologous genes among bacteria which are closely related. 
Bacteriophages often transfer toxins and virulence factors and do rarely carry antibiotic 
resistance (84,210). Bacteriophages in enterococci have been shown, although transduction of 
resistance genes to enterococci trough bacteriophages in vivo has not yet been revealed it is 
believed that phages may play a role in the spread of antibiotic resistance in enterococci 
(29,131,247).  
 
Transformation. Transformation is a process in which naked, exogenous DNA is taken up 
and recombined into the genome of a competent bacterial cell. This process may facilitate 
evasion of host defences by mediating pilin switch and transfer of resistance genes or might 
be a process for acquiring nutrient sources for the cell. Transformation may also be a 
mechanism in the repair of damaged DNA (205). Enterococci are not known to be naturally 
competent (131), thus this process is not considered an important factor in the evolution of 
this genus.  
 
Conjugation. Conjugation is carried out by Mobile Genetic Elements (MGE) such as 
conjugative plasmids and Integrative Conjugative Elements (ICE) that encode a mating 
apparatus which facilitate transfer of the cellular DNA from a donor cell to a recipient. This 
process requires close cell-to-cell contact between donor and recipient and a pore through 
which the DNA can be transferred and then recombined into the recipient genome or 
circularized as a plasmid (84,210). Conjugative plasmids can also transfer non-conjugative 
plasmids by mobilization. MGEs may carry virulence factors and they often contain genes 
encoding antibiotic resistance. Gram positive bacteria and especially enterococci use 
conjugation as a system for genetic exchange (43). 
Figure 5 shows an overview of the three mechanisms of horizontal gene transfer. 




Figure 5; Acquisition of antibiotic resistance genes.  Resistance genes (Abr) can be transferred to a 
recipient trough three mechanisms; Transformation (uptake of free, naked DNA), transduction (infection 
of a bacteriophage) or conjugation (plasmids, ICE) (Modified from Kenneth Todar, Lectures in 
Microbiology, University of Wisconsin-Madison.  
(http://textbookofbacteriology.net/themicrobialworld/bactresanti.html )  
 
1.4.2 Mobile genetic elements 
Mobile genetic elements (MGEs) are DNA fragments that mediate their own mobilization 
within or between cells (84). A vast variety of mobile genetic elements has been identified 
and new elements are continuously being found. The conjugative plasmids and transposable 
elements will be highlighted below. 
 
Conjugative plasmids 
In the bacterial cell the plasmids are replicating autonomously and controlled trough a 
negative control system; however, they may sometimes integrate into the bacterial 
chromosome. Several plasmids are self-transmissible or may be mobilized by other plasmids 
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making them able to spread to other hosts and provide them additional traits such as virulence 
and antibiotic resistance.  
 
In enterococci a plasmid classification system based on the replication (rep) genes has been 
developed. Currently 19 rep families has been identified (119) 
Conjugative plasmids encode proteins necessary for their own transfer from a donor to a 
recipient cell. These proteins involve the pili or the aggregation factors which promote cell-to-
cell contact. Before plasmid transfer, a nick is engaged at oriT (origin of transfer) by a 
relaxase, followed by transfer of a single DNA strand by a rolling-circle or theta-replication, 
trough a type IV-like secretion system, and synthesis of the second strand in both donor and 
recipient. Several genes are required for transfer of a plasmid. These includes genes for 
relaxase, the formation of a mating channel (transglycosylase), genes for energetics of transfer 
(ATPases), and genes for production of coupling proteins (34,94). Figure 6 shows the 




Figure 6; The pIP501 transfer region. Reprinted from (1) with permission from the publisher 
 
 
The conjugative transfer of plasmids in enterococci is often divided into two major groups; 
pheromone responsive plasmids and broad host range plasmids; 
 
Pheromone responsive plasmids – The communication process of pheromone responsive 
plasmids seems restricted to E. faecalis (rarely described in E. faecium) and involves the 
excretion of different small hydrophobic peptide sex pheromones which are specific for 
different types of plasmids and act as interbacterial signals. The pheromones are produced by 
a recipient and in close contact with a potential donor the transcription of a gene on the donor 
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plasmid is switched on. The result is production of an aggregation substance on the donor-cell 
surface mediating cell-cell contact between donor and recipient. The donor can now transfer 
the pheromone responsive plasmid to the recipient. Once the plasmid is transferred expression 
of this particular sex pheromone will be turned off in the recipient. Other bacterial species do 
also produce peptides similar to pheromones. For example S. aureus may induce enterococci 
to enter the aggregative state which may start intergenetic spread of plasmids. However 
transfer of vancomycin resistance by this mechanism has not yet been shown (44,94,165,178).  
 
Broad host range plasmids – are plasmids that are able to transfer between enterococci and 
other Gram positive organisms including streptococci and staphylococci. The frequency of 
transfer is generally much lower than with the pheromone responsive plasmids. Since 
staphylococci, streptococci, and enterococci share several resistance genes, the broad host-
range plasmids may well be a vehicle through which some of these resistance genes have 
spread among these different genera of bacteria (165). 
Most broad host range plasmids are identified in streptococci and enterococci and often hold 
resistance genes to a wide spectrum of antibiotics. The lower limits in size for these types of 
plasmids are in the range of 15-20 kb which is the size of the transfer region with no 
additional genes (94). 
 
Transposable elements 
Transposable elements are defined as “specific DNA segments that can repeatedly insert into 
one or more sites in one or more genomes” (Roberts et al., 2008). It is a diverse group of 
mobile genetic elements of which some are capable of excising from the bacterial 
chromosome, transfer to a recipient by conjugation and insert into the recipient chromosome. 
The simplest transposable elements are the Insertion Sequences (IS) which are small < 2.5kb 
DNA elements. They encode a transposase which is an enzyme that cuts the transposable 
element out and unite it into the DNA where it will be inserted by homologous- or non-
homologous recombination between short repeats (48).  
 
Transposable elements may be mobilized by other conjugative elements; in some cases this 
includes elements in the host chromosome (194). However transposable elements do not hold 
the phenomena of incompatibility, so conjugative transposons may interact with each other 
and with other replicative and non-replicative elements. Different variations and 
rearrangement of mobile and non-mobile elements may be formed resulting in the formation 
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of a mosaic of larger and more complex elements giving several benefits to the host (194). 
After the sequencing era started new and more complex variants of elements are frequently 
discovered and described.  These complex variants make it difficult to classify the 
transposable elements and several attempts have been proposed during the years. One way of 
classifying these elements is shown in Table 3. The composite transposons, unit transposons, 
integrative and conjugative elements and mobile genomic islands will be highlighted below.  
 
Composite transposons – These are DNA segments, often carrying one or more resistance 
genes to antibiotics, flanked by two separate IS elements of the same IS family which may or 
may not be exact replicas. Instead of each IS element transposing separately, the whole length 
of DNA spanning from one IS element to the other is moved in one unit. Composite 
transposons have been reported in enterococci. The most widespread is the Tn5281 (identical 
to Tn4001 in Staphylococcus) which hold resistance to high levels of aminoclycosides. The 
prototype Tn5281 (Figure 7) is flanked by two copies of IS256. In Enterococcus the IS 
elements within the IS256 and IS1216 families often form composite transposons (106). 
Another example of a composite transposon found in enterococci is Tn5385 which is a large 
(65 kb) complex element containing both Tn5281 and Tn5384, holding resistance to 
erythromycin, aminoglycosides, mercuric chloride, streptomycin and penicillin (191) 
 
Unit Transposons – Unit transposons encode often an enzyme which is engaged in the 
excision and integration of the element. These are often site-specific recombinases or 
resolvases. In addition the elements include one or more accessory genes in their genetic unit 
and are often flanked by inverted repeats (IR) (193). An example of a unit transposon is 
Tn1546 encoding the VanA phenotype in Enterococcus (10,142). 
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Table 3. Transposable elements in Gram positive bacteria: definitions and examples.   
Type of transposable 
element* 





Flanked by IS elements. The transposase of the IS element is responsible for the 






Unit transposons Typical unit elements encode an enzyme involved in excision and integration 
(DD(35)E or tyrosine) often a site-specific recombinase or resolvase and one or 









The conjugative transposons (CTns) belong to a group known as integrative 
conjugative elements (ICEs) which carry genes for excision, conjugative transfer 
and integration within the new host genome. They carry a wide range of 












The mobilizable transposons (MTns), also known as integrative mobilizable 
elements (IMEs), can be mobilized between bacterial cells by other ‘‘helper” 
elements that encode proteins involved in the formation of the conjugation pore 
or mating bridge. The MTns exploit these conjugation pores and generally 





Some chromosomally integrated genomic islands encode tyrosine or serine site-
specific recombinases that catalyze their own excision and integration but do not 
harbor genes involved in transfer. They carry genes encoding for a range of 
phenotypes. The name of a genomic island reflects the phenotype it confers, e.g. 




Integrated or An integrated or transposable prophage is a phage genome inserted as part of the φNM1–4  (11,227) 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 25
transposable prophage linear structure of the chromosome of a bacterium which is able to excise and 




Bacteriophage genome inserted into that of the host which requires gene products 
from ‘‘helper” phages to complete its replication cycle 
IL1403 (39) 
Group I intron Small post-transcriptionally splicing (splicing occurs in the pre-mRNA), 
endonuclease encoding element. Will home to allelic site 
Unnamed group I intron 
inserted the DNA 
polymerase gene of  
Bacillus subtilis phage 
SPO1  
(90) 
Group II intron Small post-transcriptionally splicing (splicing occurs in the pre-mRNA), 
restriction endonuclease encoding element 
Tn5397 containing  group 
II intron 
(161) 
Istron Chimeric ribozyme consisting of a group I intron linked to an IS605 like 
transposase 
CdlSt1 (30) 
Intein Small post-translational splicing (splicing occurs in the polypeptide), 
endonuclease encoding element. Will home to allelic site 
LLP-KSY1 PolA The intein database 
http://www.neb.com/neb/inteins.html 
* Not all reported elements have shown to be mobile. Adapted and modified from (193) with permission from the publisher. 
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Figure 7. Schematic presentation of the three transposons representing the transposon groups 
transferring resistance genes in enterococci. Adapted from (106) with permission from publisher. 
 
 
ICEs (Integrative and conjugative elements) 
ICEs are elements which excise by site-specific recombination and integrate like prophages 
but transfer in a covalently closed circular intermediate by conjugation like plasmids. Before 
transposing to a recipient these elements needs to excise and form a circular intermediate. 
This is a process mediated by site-specific recombinases. At times they may also require an 
excisionase. The transfer mechanism is thought to be similar to that of plasmids, though with 
a specific oriT (origin of transfer) (194).  
The circular intermediate is replicated during conjugation but replication is not required for 
maintenance of the element. However the intermediate is not self-replicating and will require 
replication factors from the host  (78). Three types of recombinases have been found to be 
involved in insertion and integration of these elements; tyrosine, serine and DDE 
recombinases (32,35). Several of the tyrosine recombinases catalyse site-specific integration 
into genes encoding tRNA (35). Most of the ICE encodes a tyrosine integrase which catalyse 
the recombination between the attachment sites attL and attR which flanks the element. This 
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would lead to the excision of a circular intermediate containing an attI site which can transfer 
to a recipient by conjugation. The element will be able to integrate at an attB site (31). The 
conjugative elements may facilitate transfer of additional DNA by including genes or by 
integrating into other elements where they may take advantage of the self-transmissibility of 
the ICE (76,215).  
 
One of the best known ICEs is the Tn916-Tn1545 family. Tn916 from E. faecalis was the first 
conjugative transposon to be identified (32,43,78). This 18kb transposon is widely distributed 
among Gram positive bacteria and especially in Enterococcus and Streptococcus. Tn916 was 
shown to insert into various sites on a plasmid, pAD1 and at several sites in the chromosome 
of a recipient bacteria (43). Within the Tn916/Tn1545 family there has been identified several 
different ICE like the Tn5382/Tn1549-like. Tn5382/Tn1549 has shown to be approximately 
34kb encoding vanB2 in enterococci. It has been shown that Tn5382/Tn1549 forms a circular 
intermediate; and transfer of the element has been shown (55,86,138). However it is not 
established whether this element is conjugative or mobilizable. An oriT and relaxase of the 
MOBp7 family has been identified. It has been proposed that Tn1549 has been transferred 
from Clostridium symbiosum to Enterococcus by a helper element (221). A vast diversity of 
ICE elements has been shown. Several of these are shaped by extensive recombination and 
formation of mosaic genomes formed by inter-ICE recombination and tandem array structures 
(87,243).  
 
 The streptococcal ICESde3396 shares several open reading frames with a putative ICE from 
S. agalacticae (GBS), S. dysgalacticae (GGS), and several genes from S. pyogenes (GAS). In 
addition, ICEde3396 harbours genes from non-streptococcal bacteria such as Enterococcus 
and Lactococcus, giving the element a mosaic structure in an 18kb internal region. This MGE 
is able to transfer to other β-haemolytic streptococci and has been shown transferable to other 
GGS, GBS and GAS.This ICE element does not contain genes for antibiotic resistance rather 
it includes genes for cadmium and arsenate resistance and a virulence gene encoding 
agglutinin receptor precursor (58). This example illustrates the dynamics and spread of such 
elements.  
 
Mobile genomic islands – Genomic islands (GEI) are part of the flexible bacterial gene pool 
and are typically discrete DNA elements between closely related bacterial strains. The 
nucleotide content of GEIs often differs from the rest of the chromosome; they are large in 
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size (10-200kb), are often inserted at tRNA genes, may be unstable, and may have a different 
codon usage and GC content than the core genome. GEIs are often flanked by 16-20bp perfect 
or almost perfect direct repeats (DR) arisen by site specific integration into the target site and 
do often act as recognition sites for excision. These elements contribute to a great extent to 
the diversification and adaptation of microorganisms and have a large impact on the genome 
plasticity and evolution, dissemination of antibiotic resistance and virulence genes, and 
formation of catabolic pathways. One hypothesis is that the GEIs embrace a family of 
elements including recognized mobile elements like ICE, conjugative transposons and some 
prophages (97,122). Genomic islands with functions that increase the fitness of the bacteria 
have probably directly or indirectly been positively selected trough evolution (97). One 
example of a mobile genomic island is the methicillin resistance (mecA) of MRSA isolates is 
located within the Staphylococcal Cassette Chromosome (SCC) region of the staphylococcal 
chromosome containing transposon within transposon features. The mecA gene is not 
originally found in S. aureus and may have been transferred from coagulase negative 
staphylococci (CoNS) which may be capable to infer resistance to methicillin. MRSA and 
other resistance phenotypes are often a result of integration of transposons containing 
resistance genes for example erythromycin (Tn554). The basic SCCmec is composed of the 
resistance genes, component of its regulatory region and the transposition genes ccrA and 
ccrB in combination or the single ccrC. The origin of SCCmec is not known however it is 
believed that the ccr and mec genes accumulated in CoNS from and unknown source followed 
by deletions in the regulatory part of the mec genes took place whereby the genes were 
transferred to S. aureus (7,112,167,212). Recently a SCCmec-like element was identified in a 
strain of Macrococcus caseolyticus (a commensal bacterium in food animals). This element 
has not previously been observed and has shown a potential mechanism for the generation of 
new SCCmec-like elements (220). This may give further knowledge of the origin of SCCmec 
and related elements. 
 
There are eight different types SCCmec (type I-VIII) described so far and each type may vary, 
showing a diversity of this mobile genomic island (62,249). Even the ccr genes are varying up 
to 5% at nucleotide level within one type SCCmec (101,176). The whole region of SCCmec 
can excise from the chromosome through the gene products of the ccr genes making SCCmec 
a presumable mobile element (189). The detailed mechanism around transfer of SCCmec is 
not yet fully understood.  
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Pathogenicity islands (PAI) are genomic islands present on the genomes of pathogenic strains 
but are not found in the genomes of non-pathogenic members of the same or related species. 
These were first described in human pathogens of E. coli but have been found in the genomes 
of various pathogens of humans, animals, and plants, both Gram positive and Gram negative 
(97). An example is the E. faecalis PAI coding for virulence genes including the gene for 
cytolysin toxin and the enterococcal surface protein (esp). In addition there are traits 
suspected to contribute to pathogenicity or altering E. faecalis relationship with the host, 
including a bile acid hydrolase and carbohydrate utilization pathways (158). An interesting 
part of this PAI is the diversity of the island between closely related strains even between 
strains belonging to the same clonal complex. McBride and co-workers hypothesize that the 
pathogenicity island in E. faecalis has entered piece by piece and not as a whole, complete 
island which later rearranged into the diversity of islands we see today. The genome of E. 
faecium has also shown to contain PAIs and other related elements (229). Recently an E. 
faecalis PAI was shown to transfer via mechanisms independent of ICE functions. Transfer of 
this particular PAI only occurred via pheromone responsive type of conjugative plasmids and 
showed horizontal transfer of all chromosomal regions including a vancomycin resistance 
transposon and alleles included in MLST (155).  
1.4.3 Host range of mobile elements 
Mobile DNA disseminates both within a bacterial species but also between different species 
and genera dependent on the host range of the element. Some elements are even able to 
transfer from bacteria to eukaryotes (e.g. Agrobacterium tumefaciens). 
 
Plasmids. As mentioned above, plasmids may have a broad host range making it able to 
spread to several species, but others are restrained to certain bacterial species. It has also been 
shown that the enterococcal plasmid pAM830 has facilitated transfer of a vanA Tn1546-like 
element to S. aureus. This plasmid was lost. Broad-host range plasmids in enterococci have 
shown to transfer between several Gram positive bacteria.  Different rep families display 
different host ranges. An example is rep family 7 and 10 which has shown to transfer to 
staphylococci, streptococci and Bacillus (119).  
 
Bacteriophages. Bacteriophages, like all viruses exhibit a defined host range. Some are 
viewed to have a narrow host range and highly specific, whereas others infect a range of 
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different bacterial species. Examples of a broad host-range bacteriophage is phage 812 which 
infect several staphylococcal species (124).  
Little is known about the enterococcal phages and their ability to spread virulence traits or 
antibiotic resistance however they contribute to a large extent to the genome diversity in E. 
faecium (120,175,229). 
The bacterial viruses are highly adaptive and continuously co-evolving with its hosts (230) 
and a particular bacteriophage may transfer a DNA element to different bacterial species. 
Certain genetic elements may be transduced by several different phages and thus disseminate 
to several different bacterial species (154).  
 
Integrative and Conjugative Elements. The host-range of a self conjugating element will 
depend on the specificity of the recombinases/integrases responsible for the conjugation. 
Tn916 from E. faecalis has shown to have a very broad host range (more than 50 different 
bacterial species from 24 genera) including both Gram positive and Gram negative bacteria 
(19,43).  
 
ICESt1 and ICESt3 in Streptococcus thermophilus has shown to be able to transfer from E. 
faecalis. These elements have also been found in S. pyogenes showing the evidence that they 
may move between different species. The two ICE elements are also closely related to 
putative ICEs in S. pyogenes, S. mutans, and S. agalacticae. In addition one of the elements is 
carrying cadmium resistance genes closely related to plasmids from Lactococcus lactis, 
Listeria innocua, S. aureus, Staphylococcus saprophyticus, and ICEs of Listeria 
monocytogenes, S. agalacticae, S. dysgalactigae, and SCCmec genomic island from 
Staphylococcus (18,26,177).  
The mixing of genes in ICEs and other genetic elements would seem to be a central 
mechanism for the exchange and spread of genes into different ecological niches (18).  
1.4.4 Integration sites 
The integration of a transposable element is not a random process. Enzymatic activity is 
required for integration of a transposable element. In prokaryotes these enzymes are mostly 
transposases, integrases and recombinases which recognize specific regions in the target DNA 
and promote homologous or non-homologous recombination between them (84). Most 
elements show some target specificity having preferences over some targets than others. The 
specificity may as well be the structure rather than the sequence of the target DNA, that is 
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bends in the DNA or the presence of other proteins bound to DNA (transcription factors) 
(49,135,242). However some transposable elements require a specific sequence in the target 
DNA for integration to occur. This may include a special attachment (att) site or a special 
order of nucleotides. Examples of this are the SCCmec in Staphylococcus aureus and phage λ 
which both integrates into an att site of the target. In SCCmec the ccrA gene are responsible 
for the site specificity of integration of the element. ccrB alone are able to initiate excision 
however at an alternative att  site. Pathogenicity islands (PAIs) have a tendency to integrate 
into a tRNA gene. Some transposons create target site immunity when they integrate. This is a 
feature where the transposons do not integrate into a site close to another transposon in the 
same target DNA (49,113,176,193,208,232). 
1.4.5 Putative  host mechanisms for protection against phages and MGE 
Bacteria may hold several mechanisms which function as immune systems against prophages. 
In Lactococcus lactis more than 50 phage resistance systems have been characterized. These 
include restriction-mechanisms which comprise phage genome uptake blocks, superinfection 
immunity, restriction modification, Clustered regulatory interspaced short palindromic repeats 
(CRISPR) and mutations (96,117) and abortive infection systems (abi). The section below 
will focus on the two latter mechanisms that recently have been discovered in Enterococcus 
sequences – abi and CRISPR 
 
Some bacteria harbour resistance mechanism to phage infection denoted exclusion or abortive 
infection (Abi). This mechanism starts as a normal phage infection including adsorption and 
injection of DNA into the host. However the phage development is then interrupted leading to 
the release of no or a few progeny particles. The infected cell will die and further spread of 
the phage is prevented in the bacterial population. Several Abi systems are known, most of 
them from Lactococcus and most are plasmid encoded (40). A Tn5382-vanB containing MGE 
transferable from Streptococcus to Enterococcus have showed to contain an abiG system. 
This is the first report of such a sequence in enterococci (Paper III). The abi genes are also 
known to be involved in increased stress tolerance of the host. These genes are commonly 
found in Streptococcus (114).  
 
CRISPR are found in the genome of about 40% of bacterial genomes and nearly all archaeal 
genomes (15). The CRISPR are short (24-48 nt) repeats split by unique spacer sequences with 
similar size as the repeats and most often flanked by CRISPR-associated (cas) genes. The 
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CRISPR spacer sequences and the associated repeat are transcribed into small RNAs that 
protect the organism from specific bacteriophage infection and horizontal gene transfer of 
specific MGE and plasmids by targeting the interfering DNA (156).  
 
Interestingly, the E. faecalis OG1RF contains two CRISPR loci, however the genome of. E. 
faecalis V583 is absent of prophages, has no CRISPR loci and consist of several MGEs which 
include  prophages or prophage remnants. It has not yet been proven but the hypothesis is that 
the CRISPR loci in OG1RF are the main reason for the lack of prophages and MGEs in this 
strain (25). CRISPRs has been located in E. faecium, however no cas genes has been linked to 
them so they are not considered functional (229).  
 
1.4.6 Plasmid maintenance.  
To ensure their survival in the bacteria during cell division, the plasmids have developed 
several systems. Low copy number plasmids associated with antibiotic resistance and 
pathogenicity is prone to contain core regions which are mandatory for the replication, 
segregation and transfer. The stability of the segregation of the plasmid may be maintained 
trough a specific system where cells failing in receiving a copy of the plasmid will not survive 
due to selective killing or growth impairment. These mechanisms are collectively known as 
Toxin-Antitoxin (TA) or plasmid addiction systems (Figure 8), and include a stable toxin and 
an unstable antitoxin produced within the cell. The TA-systems, in addition to promote 
selective killing promote active partitioning and resolution of multimers by site-specific 
recombination (91,105). Several TA-systems has been described, in E. faecium the axe-txe, 
the mazEF, relBE and the ω-ε-ζ-system has been detected (105,160,195). The pneumococcal 
epsilon zeta Antitoxon Toxin (PezAT) system have recently been detected in an enterococcal 
sequence indicating that more TA-systems may be found in these species (Paper III).  
Toxin –Antitoxin systems have also been shown located on the prokaryotic chromosome 
(168) and on MGEs (244). For instance the putative PezTA system in enterococci is located 
on a MGE transferred from Streptococcus (Paper III). The function of chromosomally 
encoded TA-systems is being discussed however it is hypothesised that they may be involved 
in growth control and stress response (41,42), stabilization of MGE (244).  
 
 




Figure 8; A general outline of cell death induced by plasmid-located TA modules. The toxin (yellow) and 
antitoxin (orange) proteins form a complex that cancels the harmful activity of the toxin. The antitoxin is 
degraded by a protease more rapidly than the toxin, but the toxin is constantly bound by fresh antitoxin. 
As long as the plasmid is maintained, the cell tolerates presence of the TA complex (left). If a 
missegregation event or replication defect produces a plasmid-free cell (right), the degraded antitoxin 
cannot be refilled so that the free toxin attacks an intracellular target to cause death or growth restriction 
of the plasmid-free cell.  Reprinted with permission from publisher  (106).  
 
1.4.7 Horizontal gene transfer – In vivo  
The community of microbes in the GI tract changes between and within adults and the 
bacterial community of an infant are different from an adult (137). A habitat will at all times 
be populated by resident species in addition to several transient species which are only filling 
an empty niche (73).  The gastro intestinal environment has revealed to be important for gene-
flux both within transient and resident species and between them. In vivo studies have shown 
that the condition in the mammal GI tract in fact favours HGT and that this has been difficult 
to reproduce under laboratory conditions. Transient bacteria may transfer resistance 
determinants to the resident flora even without colonizing (52). Spread of resistance genes 
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may come from ingested soil and water bacteria via contaminated food and drinks as well as 
from human pathogens (198).  
 
The E. faecium colonize the GI tract of humans and animals at high levels (187). Studies have 
shown that Tn5382/Tn1549-like elements containing vanB2 have been identified in other 
genera than Enterococcus belonging to the normal gastrointestinal flora such as Clostridium, 
Ruminococcus, Eggerthella, and Streptococcus (12,54,64). A study performed by Seville et 
al., (201) showed that 5 of 6 faecal metagenomes contained the Tn5382/Tn1549-like integrase 
gene which suggests that this family of elements are common in the microbiota inhabiting this 
niche and are involved in horizontal gene transfer in the human intestinal flora. In addition the 
vanB2 resistant conjugative transposon Tn5382/Tn1549-like has been shown to transfer from 
Clostridium to Enterococcus in the gut of gnotobiotic mice (138). Fecal carriage of vanB 
mainly of the vanB2 subtype has been observed at high rates in the absence of cultivable VRE 
both for community and hospital specimens (64,92,248). 
 
Although the GI tract is a well known environment for bacterial colonization and spread of 
antimicrobial resistance determinants the oral cavity may be even a better place for spread of 
resistance determinants. The oral cavity contains several ecological habitats and is in contact 
with a number of growth substrates via the food eaten. The number of bacterial species in the 
oral cavity is thought to be up to 1000 (194).  
 
E. faecium has been found very rarely in the oral cavity. However there is a high prevalence 
of tetracycline resistance in the oral E. faecalis which may be a result of dissemination of a 
tet(M) containing Tn916-related element in the oral microbiota (211). The tet(M) tetracycline 
resistance gene and the Tn916 integrase has shown to be most prevalent in the human oral 
metagenome (201). 
Antibiotic pressure may not only affect the microbial flora, but also promote transfer of 
elements encoding resistance to the particular drug. In addition bacteria growing in biofilms 
have higher rates of transfer of genetic elements than planktonic cells due to both the 
closeness of the bacteria and the stability of the mating pairs in order for conjugation to be 
successful (148,194). For the non-motile enterococci biofilm formation will be an important 
factor for transfer (89).  
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The presence of enterococci in the GI tract of food-animals leads to a high risk of 
contamination of meat during slaughtering. Enterococci have been isolated from beef, pork 
cuts and cheese. E. faecium has even been isolated from pork meat and salami (79,209). 
Enterococci and VRE has been isolated from various environmental surfaces such as remote 
controls and daily newspapers within hospital environments revealing the ease of 
contaminating the exteriors which we all may be in contact with (93). It has been shown that 
the hospital environment play an evident role in the transmission of VRE between patients 
(69,174,182). The clothes of health care workers are also subjected for contamination and 
dissemination of VRE in addition these organisms survive for a long time in a hospital 
environment. In one study enterococci survived for more than 90 days on polyester, 
polyethylene, and on hospital clothing and drape (27,174).  
 
Resistance determinants may also reach outside the hospital environment where enterococci 
may serve as  a reservoir for the spread of MGE for example through the sewage (118) and  
even our domestic animals (57). 
 
1.5  Molecular epidemiology and typing methods  
Molecular epidemiology is a field in biology which quite recently emerged from integration 
of molecular biology into the traditional epidemiologic research. This has become an essential 
field for the development of medical diagnostics and public health prevention strategies and is 
important in the determination of physical sources of an outbreak, biological relationships, 
transmission routes and important virulence genes which the pathogenic organism holds. The 
requirement for suitable typing methods is particularly important in cases where pathogens 
increase in prevalence or acquire qualities increasing their capacity to cause disease. In these 
cases identification below the species is required (226). 
Several different typing methods has been described, such as amplified fragment length 
polymorphism (AFLP), Multiple Loci VNTR Analysis (MLVA), PFGE and MLST, the two 
latter are described below. Guidelines have been given for interpreting the results of the 
different typing methods, but there is generally a lack of standardized criteria and running 
conditions. This makes it difficult to compare results between different laboratories. Which 
method to use is also a crucial question and the choice must be taken on the basis of good 
knowledge of the organism. Enterococci are a group which vary considerably in their genetic 
content due to extensive recombination amd horizontal gene transfer (140,197,222).  This is a 
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factor which must be taken into account when choosing typing method for epidemiological 
research of enterococci.    
 
Pulsed Field Gel Electrophoresis (PFGE) has been considered a gold standard of the typing 
methods for several medically important bacteria and is essentially the comparison of large 
genomic DNA fragments after digestion with restriction enzymes and the DNA fragments 
separated by agarose gel electrophoresis designed for separating large fragments and giving a 
fingerprint of the whole genome. The bacterial chromosome is typically a circular molecule 
and enzymatic digestion yields several linear DNA molecules at different lengths. By 
comparing two isolates that are the same strain (i.e. clonal), the sites at which the restriction 
enzymes act on the DNA and the length between these sites would be identical. If the DNA 
banding patterns between isolates is identical the isolates are considered the same strain. If 
two isolates are not the same strain, then the sites at which the restriction enzymes act on the 
DNA and the length between these sites would be different and their DNA banding patterns 
will be different. PFGE has been important for the identification of clonal relatedness between 
isolates that are epidemiologically associated in time and space  (38). By comparing DNA-
band patterns one may identify closely related or more distantly related samples (213). 
Transfer of genetic elements from a donor to a recipient will be visible as shift of bands on the 
gel. A disadvantage is then that several differences in bands will lead to the conclusion that 
the isolates compared are distantly or not related where they in fact may be closely related 
isolates with high frequency of horizontal gene transfer. The resolution power is a limiting 
factor which makes it difficult to compare gels and reproduce results (6). The advantage of 
this technique is that rearrangements in the genome such as insertions and deletions of genetic 
elements may be visible and the surveillance of for example an outbreak is possible such as in 
the case of enterococci. Very small changes may though not be visible. However the method 
is not suitable for global and long-term epidemiological studies (197).    
 
Multi Locus Sequence Typing (MLST) is based on variations in mutations in the sequence of 
450-500 bp from seven housekeeping genes (115). The method was developed to overcome 
the challenge of comparing the non standardized typing methods between laboratories. 
Nucleotide data from several alleles of the seven genes is stored in a database giving the 
advantage of a good resource for global epidemiology and high discriminatory power between 
isolates due to the quite large number of genes compared (153). Housekeeping genes are not 
target for extensive mutation over a short period of time; however a certain change over time 
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is expected. For each allele, the different sequences are assigned a distinct allelic profile 
number. The profile of all seven alleles is defined a sequence type (ST). The number of 
nucleotide differences is not related to the allele number given. The basis for this is that one 
genetic event that result in a new allele may occur by point mutation or recombinational 
replacement. Sequence types are grouped into clonal complexes by their similarity to a central 
allelic profile. These profiles are often identified by a database called eBURST which 
incorporates a simple model of bacterial evolution in which strains increasing in frequency 
diversify to form clusters of similar genotypes, descended from the founding strain. Isolates 
of an expanding founding strain initially have the same allelic profile, but diversification 
result in the appearance of variants in which one change in a MLST loci give a single locus 
variant (SLV). A clonal complex if defined in eBURST as a group of STs in a population that 
share six of seven alleles with at least one other ST in the group (222). MLST and eBURST 
has been used for typing of isolates belonging to CC17 genogroup, which is a large complex, 
however the algorithm was not optimal for investigating bacteria with such high 
recombination frequencies. Later new algorithms has been developed displaying that CC17 is 
not one complex developed from a single ancestor. It is more probable that the STs belonging 
to CC17 are not related but rather are several complexes evolved in parallel (85,99,241). This 
was also observed in a study of S. agalacticae where strain classification methods, like 
MLST; did not reflect the real genetic diversity which could be described by whole-genome 
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2. Aims of study 
 
The general aim of this work was to investigate factors and mechanisms important for 
horizontal gene transfer in E. faecium.  
 
Specific aims;  
 
Paper I.  
• Investigate the clustering of VanB-type vancomycin resistant E. faecium at the Örebro 
University Hospital between November 2002 and April 2004 using clinical and 
demographic data to identify potential risk factors.  
• Characterize the strains with regard to clonal relatedness and possible mobile genetic 
elements involved.  
 
 
Paper II.   
• Identify ccrABEnt recombinase-like genes in the E. faecium DO genome in silico, 
examine the distribution of ccrABEnt genes in different enterococcal species and the 
expression of the ccrABEnt in DO. 
 
 
Paper III.  
 
• Identify and characterize the conjugative 100-kb chromosomal element supporting 
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3. Summary of papers 
Paper I 
 
Clustering of polyclonal VanB-type vancomycin resistant Enterococcus faecium in a low-
endemic area was associated with CC17-genogroup strains harbouring transferable 
vanB2-Tn5382 containing pRUM-like plasmids with axe-txe plasmid addiction systems.  
Eva Bjørkeng, Gunlög Rasmussen, Arnfinn Sundsfjord, Lennart Sjöberg, Kristin Hegstad, 
and Bo Söderquist. Submitted  
Background 
The Nordic countries have for a long time been considered a low-endemic area with respect to 
human VRE infections. A clustering of vancomycin resistant Enterococcus faecium was 
detected over a time period of 18 months in November 2002 - April 2004.  Seventeen isolates 
obtained from 15 patients from the University Hospital in Örebro were analyzed. The average 
age of the patients was 60.7 years (range 37-89), and there were eight male and seven 
females. Most of the patients had underlying diseases and/or conditions such as diabetes 
mellitus, renal insufficiency, haematological malignancies, other active malignancies, organ 
transplant recipient, liver failure, recent surgery, stay in intensive care unit, and 
immunosuppressive therapy such as high-dose corticosteroids or chemotherapy. During the 
last three months all patients had been treated with antimicrobial agents such as vancomycin 
(n=5), cephalosporins (n=9), fluoroquinolones (n=7), aminoglycosides (n=3) or metronidazole 
(n=7). All of the 15 patients had received prior treatment with at least 2 of these antibiotics. 
Of all 15 patients 12 seemed to have an infection caused by VRE while the remaining three 
were only colonized. Positive cultures with VRE were yielded from blood, wounds or 
abscesses, urine, ascites, a tip from a urinary catheter, and faeces. 
 
Summary of results 
Fourteen of the isolates grouped in 3 different PFGE-types whereas the last 3 isolates held 
unique PFGE-patterns. The isolates had multi-locus sequence-types ST17 (n=5), ST18 (n=3), 
ST125 (n=7), ST262 (n=1), and ST460 (n=1) which all belong to the successful hospital 
adapted genogroup previously designated CC17. All 17 isolates contained the virulence genes 
EfaAfm and sgrA and most of the isolates harboured ecbA and acm all associated with CC17. 
Only a few of the isolates harbored the virulence genes hyl and esp. 
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All 17 isolates belonged to the vanB2 subtype expressing various levels of vancomycin-
resistance (MIC 8 to > 256 mg/L) and susceptibility to teicoplanin in accordance with the 
genotype. The first isolate had a unique PFGE-type and a chromosomally located transferable 
vanB2-Tn5382 element whereas the other five PFGE-types had Tn5382 located on pRUM-
like plasmids containing the plasmid addiction system axe-txe. The resistance pRUM-
plasmids were mainly of 120-kb and supported intraspecies vanB-transfer by filter mating. In 
one patient (patient 6) both PFGE type III ST17 and later PFGE-type I ST125 were isolated. 
Plasmid transfer in this patient seems to have resulted in a more successful clone (PFGE-type 




























ccrABEnt serine recombinase genes are widely distributed in the Enterococcus faecium 
and Enterococcus casseliflavus species-groups and expressed in E. faecium.  
Eva Katrin Bjørkeng, Girum Tadesse Tessema, Patrick Butaye, Rob Willems, Johanna 
Ericsson Sollid, Arnfinn Sundsfjord, Eirik Wasmuth Lundblad, and Kristin Hegstad.  
re-submitted Microbiology  
 
Background 
Recombinases are proteins facilitating the exchange of DNA fragments and are essential for 
bacterial genome plasticity. The staphylococcal cassette chromosome (SCC) element is a 
family of mobile genetic elements serving as vehicles for exchange of genetic information in 
staphylococci, with the support of the recombinase (ccr)-genes. The presence, distribution, 
phylogeny and expression of cassette chromosome recombinase (ccrABEnt) genes, homologus 
to the staphylococcal ccrAB genes, were examined in 421 enterococcal isolates distributed 
between 13 species from Europe, USA, and Australia.   
 
Summary of results 
A total of 118 (28 %) isolates were positive for ccrAB genes by PCR and some were 
confirmed by Southern hybridization and DNA sequencing. The ccrABEnt genes were present 
in Enterococcus faecium (n=58/216, 27 %), Enterococcus durans (n=31/38, 82 %), 
Enterococcus hirae (n=27/52, 50 %), Enterococcus casseliflavus (n=1/4, 25 %), and 
Enterococcus gallinarum (n=1/2, 50 %). In eight other species tested, including Enterococcus 
faecalis (n=94), ccrABEnt genes were not found. Analysis of ccrABEnt gene sequences (n=38) 
from five different species showed 94-100 % identity between different enterococcal isolates 
at the nucleotide level. Both ccrAEnt and ccrBEnt genes formed two distinct clades. ccrABEnt 
genes from the human isolates were clustered in clade I, except for ccrAEnt from E. faecium 
E1304. The two phylogenetic trees showed incongruence between the ccrAEnt and ccrBEnt 
genes for 11 of the animal isolates, which mean that the ccrAEnt and ccrBEnt belonged in 
different clades for these isolates. Phi test showed no statistical significant evidence for 
recombination within the sequenced regions of the ccr genes. 
 
Expression analysis of ccrABEnt genes from the E. faecium DO strain was performed under 
normal growth conditions and showed that ccrABEnt genes were constitutively transcribed as a 
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bicistronic mRNA. The expression was lower during log- than stationary-phase in relation to 
total mRNA. ccrABEnt genes were detected both in the hospital derived clonal complex (CC) 
17 strains (n=10/25, 40 %) and non-hospital non-CC17 strains (n=6/16, 38 %) of E. faecium. 
Specific sequence types within CC17 were represented by both ccrABEnt -positive and -
negative isolates which suggests an introduction or deletion of ccrABEnt in E. faecium through 































Sequence analyses of an approximately 100-kb chromosomal element supporting 
transfer of vanB2-Tn5382/Tn1549 from Streptococcus lutetiensis to Enterococcus faecalis 
and E. faecium.  
Eva K. Bjørkeng, Erik Hjerde, Eirik W. Lundblad, Johanna E. Sollid, Arnfinn Sundsfjord, and 
Kristin Hegstad. In manuscript.  
 
Background 
A 100-kb vanB2-containing element has previously been identified in a human clinical isolate 
of Streptococcus bovis and in a veal calf faecal strain of S. lutetiensis designated 5-F9. The 
vanB2 gene demonstrated to be part of a Tn5382/Tn1549-like transposon in S. lutetiensis 5-
F9. The 100-kb element transferred from streptococci to E. faecalis and E. faecium. However, 
further transfer between enterococci required a helper plasmid indicating that the 
streptococcal host may harbour factors necessary for transfer which are not transferred with 
the 100-kb element or that these factors do are functional within enterococci. 
 
Summary of results 
The E. faecium transconjugant MM5-F9a constructed by transfer of a 100-kb vanB2-
Tn5382/Tn1549 element from S. lutetiensis 5-F9 to the E. faecium recipient BM4105-RF was 
used to generate a BAC library. An 82-kb contig of the element was sequenced and annotated 
and showed to contain 67 ORFs. This element was designated Sluvan.  A smaller 9-kb contig 
with 9 ORFs was also identified and a possible location within the 82-kb contig was found but 
not verified. The 82-kb contig of Sluvan was shown to contain vanB2-Tn5382/Tn1549 which 
had integrated into parts of a streptococcal ICESde3396-like element. The parts of 
ICESde3396-like that were located in Sluvan included a non-functional abortive infection 
protein system, some components of a type IV secretion system, a putative mobilization 
protein of the MobC family and a relaxase. Several other putative streptococcal genes were 
found located in Sluvan including a putative virulence gene, a PezTA (Toxin-Antitoxin) 
system, an ISL3-family transposase and a serine recombinase. The 9-kb contig differed from 
the rest of the Sluvan element in which the origins of the genes, were most importantly, a 
transposase of the IS30 family, a TnpX site-specific recombinase, two relaxases and 
hypothetical proteins from Faecalibacterium, Lactobacillus and Clostridium.  
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The transferable Sluvan element seems to consist of a mosaic of genes originating from 
several streptococcal species and other faecal bacteria in addition to the vanB2-containing 
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4. General discussion 
Enterococci are well known for their ability to acquire and transfer mobile genetic elements, 
including plasmids and transposons, both within the enterococcal species and to other bacteria 
such as Staphylococcus aureus. The unique ability of the enterococci to gain resistance 
determinants, in addition to their intrinsic antimicrobial resistances and their capacity to 
survive the harsh hospital environment, has enabled the enterococci to become a major 
nosocomial challenge worldwide. Despite the known high genetic transferability of the 
enterococci, very little is known about the mechanisms of gene transfer, the composition of 
relevant mobile genetic elements, and their relative contribution to the dissemination of 
antimicrobial resistance. However, spread of mobile genetic elements has been observed in 
the gastrointestinal tract from commensal bacteria to enterococci and further dissemination of 
genes from the enterococci to other more pathogenic bacteria in the bowel flora is a 
possibility (64).  Transfer of resistance genes, especially vancomycin resistance, in hospital 
settings, and the spread of hospital adapted clones of enterococci has become a problem, even 
in low-antibiotic use areas such as Scandinavia. The observation that successful clones and 
selected plasmids may give rise to hospital outbreaks makes the challenge even more 
complex. To be able to limit outbreaks of VRE, rapid and good methods for detection and 
surveillance is crucial.  
In paper I PFGE and MLST were used to investigate the clustering of a polyclonal VanB-
type vancomycin resistant Enterococcus faecium in Sweden during a period of 18 months. 
The two methods were used in combination to increase the resolution power.  In MLST only 
seven housekeeping genes are taken into consideration when typing isolates. This gives no 
opportunity to look at the whole bacterial genome. This is a disadvantage when investigating 
bacterial species with high recombination frequencies, such as E. faecium, and may give a 
contracted view of the evolution. Transfer of genomic elements, genomic rearrangements and 
the presence of plasmids will not be observed which may be a key point in understanding the 
actual epidemiology.  
 
The Örebro clustering of VanB-type VRE (paper I) was a good example of the importance of 
combining MLST and PFGE to enable a better molecular epidemiological resolution. The 
presence of two major ST-types and single locus variants of these give the impression of less 
genomic variability than PFGE-typing. By using PFGE the genetic rearrangements may be 
visible as seen when comparing subtypes within the two major PFGE types (I and III) in this 
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VRE cluster. However, the combined use of PFGE typing and plasmid analyses indicated that 
spread may be due to unique clones, bur are more likely due to a prominent plasmid spread 
among several different clones. A pRUM plasmid, shown to contain both Tn5382 and a 
plasmid addiction system (axe-txe), was the probable cause of vanB dissemination during the 
first 9 months of the clustering. However, PFGE type I ST125 became prominent during the 
last 6 months. Thus, a successful combination of a stably maintained pRUM-like plasmid 
containing vanB2-Tn5382-like has established in a PFGE type I ST125 background.  
 
All VRE isolates were found to be E. faecium carrying the vanB2 subtype as an integral part 
of the conjugative transposon Tn5382.  This is typical for the vanB2 subtype (51,54,223,250). 
High rates of faecal vanB carriage primarily of the vanB2 subtype have been described in both 
community and hospital samples despite the absence of cultivable vancomycin resistant 
enterococci (65,74). Studies have also shown that both oral and subcutaneous distribution of 
several antibiotics including vancomycin, metronidazole and cephalosporins are associated 
with persistent high-density intestinal VRE colonization and colonization of other 
vancomycin resistant Gram positive microorganisms. However, vancomycin is only 
administrated orally to treat Clostidium difficile enterocolitis and thus play a limited role in 
the acquisition of VRE in the GI tract of the Örebro patients (3,66,68,102). Studies also report 
that use of fluoroquinolones may be associated with VRE colonization (37,102). Selective 
concentrations of intravenous administrated vancomycin in the GI tract has been indicated 
only when the drug was given over a period of more than 5 days (50). Thus, it may be more 
likely that other antimicrobial agents have more profound role in the Örebro setting. Most of 
the patients in this study had received vancomycin, metronidazole, cephalosporins, 
fluoroquinolones or combinations of two or three of these agents. The spread of the mobile 
genetic element vanB2-Tn5382 may have been increased by this selective pressure. Tn5382-
like elements containing vanB2 have been identified in other bacterial species belonging to 
the normal gastro-intestinal flora (12,54,64). Tn5382-like has been shown to transfer from 
Clostridium to Enterococcus in the gut of germ free mice during vancomycin exposure (64). 
Thus, a selective antimicrobial environment may promote transfer and selection of seldom 
transfer events of Tn5382-like from Clostridium or another genus present in the normal gut 
flora to enterococci.  
 
Transfer of mobile genetic elements are dependent on recombinases and integrases which 
serves as “scissors and glue” for the excision and integration of the element. In order to 
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understand the mechanisms for horizontal gene transfer in enterococci it is essential to survey 
these genes. In paper II, genes homologous to the staphylococcal recombinase genes ccrA 
and ccrB were identified in Enterococcus. In staphylococci these genes are responsible for the 
excision and integration of the staphylococcal cassette chromosome (SCC), which is generally 
known for carrying methicillin resistance (SCCmec). The enterococcal ccrABEnt genes 
resembled the staphylococcal ccrAB proteins in several ways, in addition to nucleotide and 
protein sequence. The ccrABEnt were linked and constitutively transcribed as a bicictronic 
mRNA. The genes were not found in all enterococcal species, which is also the case for 
staphylococci. The surrounding regions of the ccrABEnt showed a variable pattern, but all 
tested isolates were positive for a transposase gene. The order of the surrounding genes was 
not conserved. These observations are consistent with the regions neighbouring the 
staphylococcal ccrAB. SCC may carry the genes conferring methicillin resistance but can also 
be a tool for genetic exchange of other genes among staphylococcal species (125). Our study 
showed 6 % and 4 % sequence variation in ccrAEnt and ccrBEnt genes, respectively. This is 
also in concordance with the ccrAB genes which has shown up to 4 % variation within the 
genes (101).  
 
The ccrABEnt genes both clustered into two major clades, clade I and II. The majority of the E. 
faecium were localized in clade I, whereas the other enterococcal species tested were mostly 
localized in clade II. E. hirae seems to be more dispersed between the two clades in ccrAEnt. 
Except for ccrAEnt in one isolate of E. faecium the ccrABEnt genes of the human isolates were 
clustered in clade I, whereas the animal isolates were found in both. The two phylogenetic 
trees were incongruent for some of the animal isolates, which suggest recombination of the 
ccrEnt genes. The results are in congruence with previous findings in staphylococci, where the 
ccrAB pair may also divide into different clades. 
 
ccrABEnt genes were found only in isolates belonging to the E. faecium- and E. casseliflavus-
species groups. These belong to the same tree-branch in phylogenetic trees based on 
enterococcal 16S rDNA or sodA gene diversity (63,184). Absence of ccrABEnt in the other 
species could be explained by the lack of integration sites or by a low number of isolates 
tested, except for E. faecalis. Optionally, the ccrABEnt genes in these isolates may exhibit such 
a low sequence identity to the ccrABEnt genes identified in this study that they are missed 
using our PCR and hybridisation conditions. The observation that the enterococcal species 
harbouring ccrABEnt genes belong to the same branches in the ccrABEnt phylogenetic tree as in 
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the 16S rDNA/sodA phylogenetic tree may also indicate that these genes are only present in 
the E. faecium- and E. casseliflavus-species groups. 
 
The ccrABEnt genes are located at the very end of a large contig (contig 655) in the sequenced 
E. faecium DO. We do not have the knowledge of the genes downstream of the ccrABEnt, thus 
it is difficult to predict whether the two genes are involved in the excision and integration of a 
genetic element as seen in staphylococci. However upstream of the ccrABEnt  genes there are 
several  transposases and hypothetical genes which may be part of an integrative element.  
However, based on the function of the staphylococcal ccr, genes we may speculate that the 
ccrABEnt may be involved in recombinations within the enterococcal cell and may be 
contributing to the enterococcal dynamics of the genome. If this is true we may further 
speculate that these genes may aid transfer of genes out of the cell when including a helper 
plasmid containing the factors needed.  
 
If the ccrABEnt are involved in genome plasticity then why do only some enterococci contain 
these genes, and why are we not able to see these genes in all isolates belonging to the same 
species. If these genes are achieved trough “gain” or “loss” we may speculate that there are 
factors such as enzymes in the genomes of some isolates which may contribute to such events.   
 
In Paper III we set out to investigate a vanB2-Tn5382/Tn1549 containing ~100-kb 
conjugative element from S. lutetiensis. This particular element has been shown to transfer by 
conjugation from S. lutetiensis to E. faecium and E. faecalis. However, retransfer of this 
element within enterococci has not been seen without a helper plasmid. We aimed to search 
for the content of this genetic element and the genes that may be involved in the transfer 
process. The sequenced 82 kb element which we designated Sluvan was shown to contain a 
large parts homologous to an ICE element – ICESde3396 previously found in S. dysgalacticae 
(58), in addition to several other putative streptococcal genes, including a toxin-antitoxin 
system and components of a type IV secretion system. The latter is known to be involved in 
conjugative transfer in bacteria. Toxin-antitoxin (TA) systems have been known to be part of 
a stabilising system for plasmids. However there is evidence for these systems also being part 
of a stabilising system for chromosomal ICE elements in addition to being involved in stress 
response. We may hypothesize that the TA system is involved in stabilising the Sluvan 
element. In addition to the 82 kb Sluvan element we sequenced a 9 kb element which exact 
location was not found, however there are indications that this element should be located 
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within the Sluvan. This smaller element contains highly repetitive sequences and A+T rich 
sequences which may present a problem for the assembly and attempts to find the 
localization. The 9 kb element contained several genes from other faecal bacteria. Sluvan 
showed to be a mosaic element of genes from several different species which demonstrate a 
classical example of the evolution of mobile genetic elements and genomic plasticity. The 
species which have donated genes to the Sluvan are typically bacteria colonizing the 
gastrointestinal tract where there is a high frequency of horizontal gene transfer compared to 
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5. Concluding remarks 
Enterococci, mainly E. faecium and E. faecalis, have during the last decades developed from 
being considered harmless into one of the most important causes of hospital acquired 
infections in the western world. MGEs have been seen as major contributors to the evolution 
of enterococci and especially in hospital adapted strains.  
 
The presented studies are contributions to the process of finding some of the missing pieces 
needed for understanding this rapid development in enterococci. 
We have in paper I investigated the molecular evolution of a clustering of vancomycin 
resistant E. faecium at a University Hospital in Sweden. This particular incidence 
demonstrated the complexity and dynamics of vancomycin resistant E. faecium and how 
MGEs play important roles in the dissemination of VRE in a hospital setting. We were able to 
investigate enterococcal evolution closely and see the factors involved. The conjugative 
transposon Tn5382/Tn1549 carrying the vanB resistance genes integrated in a particular 
plasmid background (pRUM) containing a plasmid addiction system hypothesised to 
contribute to stability and maintenance of the plasmid when transferred into a new strain.  
 
Several factors are needed for transfer of MGEs both inter- and intracellularly. In paper II 
putative ccr recombinase genes were found in E. faecium. The ccr genes have previously only 
been found in staphylococci where they are involved in the movement of the SCC elements. 
The enterococcal ccr genes (ccrEnt) were shown to be expressed in E. faecium and were 
located in five enterococcal species belonging to the E. faecium- and E. casseliflavus species 
groups. Considering the role these genes play in staphylococci we hypothesize that these 
genes are involved in enterococcal chromosomal dynamics and that recombination may be a 
driving force for enterococci acquiring these genes.   
 
In enterococci several MGEs have been discovered. One of them is a 100-kb element 
encoding vancomycin resistance as part of transposon Tn5382/Tn1549. This 100-kb element 
which we in paper III designated Sluvan, transferred from Streptococcus lutetiensis to E. 
faecium and E. faecalis. The Sluvan element showed a classical example of genetic dynamics 
by the structure of a vanB2-Tn5382/Tn1549 transposon most often found in enterococci, 
inserted into parts of a streptococcal ICE region constituting about half of the Sluvan element. 
The remaining parts of the Sluvan were made of genes from several streptococcal species and 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 51
other bacteria normally located in the gastrointestinal tract of humans and animals. This may 
lead us to believe that transfer of genes to Sluvan may have occurred in the gastrointestinal 
tract.  
 
The enterococcal genome is quite complex and highly dynamic, and there are several factors 
contributing to the success of the hospital adapted enterococci. In the work presented in this 
thesis a few new facets has been added to the ever increasing complexity of mobile genetic 































 1.  Abajy, M. Y., J. Kopec, K. Schiwon, M. Burzynski, M. Doring, C. Bohn, and E. 
Grohmann. 2007. A type IV-secretion-like system is required for conjugative DNA 
transport of broad-host-range plasmid pIP501 in Gram-positive bacteria. J.Bacteriol. 
189:2487-2496. 
 2.  Abraham, L. J. and J. I. Rood. 1987. Identification of Tn4451 and Tn4452, 
chloramphenicol resistance transposons from Clostridium perfringens. J.Bacteriol. 
169:1579-1584. 
 3.  Al-Nassir, W. N., A. K. Sethi, Y. Li, M. J. Pultz, M. M. Riggs, and C. J. Donskey. 
2008. Both oral metronidazole and oral vancomycin promote persistent overgrowth of 
vancomycin-resistant enterococci during treatment of Clostridium difficile-associated 
disease. Antimicrob.Agents Chemother. 52:2403-2406. 
 4.  Alekshun, M. N. and S. B. Levy. 2007. Molecular mechanisms of antibacterial 
multidrug resistance. Cell 128:1037-1050. 
 5.  Amyes, S. G. 2007. Enterococci and streptococci. Int.J Antimicrob.Agents 29 Suppl 
3:S43-S52. 
 6.  Antonishyn, N. A., R. R. McDonald, E. L. Chan, G. Horsman, C. E. 
Woodmansee, P. S. Falk, and C. G. Mayhall. 2000. Evaluation of fluorescence-
based amplified fragment length polymorphism analysis for molecular typing in 
hospital epidemiology: Comparison with pulsed-field gel electrophoresis for typing 
strains of vancomycin-resistant Enterococcus faecium. J.Clin.Microbiol. 38:4058-
4065. 
 7.  Archer, G. L. and D. M. Niemeyer. 1994. Origin and evolution of DNA associated 
with resistance to methicillin in staphylococci. Trends Microbiol. 2:343-347. 
 8.  Arias, C. A., G. A. Contreras, and B. E. Murray. 2010. Management of multi-drug 
resistant enterococcal infections. Clin.Microbiol.Infect.  
 9.  Arias, C. A. and B. E. Murray. 2009. Antibiotic-resistant bugs in the 21st century a 
clinical super-challenge. N.Engl.J Med 360:439-443. 
 10.  Arthur, M., C. Molinas, F. Depardieu, and P. Courvalin. 1993. Characterization of 
Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of 
depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J.Bacteriol. 
175:117-127. 
 11.  Bae, T., T. Baba, K. Hiramatsu, and O. Schneewind. 2006. Prophages of 
Staphylococcus aureus Newman and their contribution to virulence. Mol.Microbiol. 
62:1035-1047.  
 12.  Ballard, S. A., K. K. Pertile, M. Lim, P. D. R. Johnson, and M. L. Grayson. 2005. 
Molecular characterization of vanB elements in naturally occurring gut anaerobes. 
Antimicrob.Agents Chemother. 49:1688-1694. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 53
 13.  Baquero, F., T. Coque, and R. Cantón. 2003. Antibiotics, Complexity, and 
Evolution. ASM News 69:547-552. 
 14.  Barie, P. S. 1998. Antibiotic-Resistant Gram-Positive Cocci: Implications for Surgical 
Practice. World Journal of Surgery 22:118-126.  
 15.  Barrangou, R., C. Fremaux, H. Deveau, M. Richards, P. Boyaval, S. Moineau, D. 
A. Romero, and P. Horvath. 2007. CRISPR provides acquired resistance against 
viruses in prokaryotes. Science 315:1709-1712. 
 16.  Bell, J., J. Turnidge, G. Coombs, and F. O'Brien. 1998. Emergence and 
epidemiology of vancomycin-resistant enterococci in Australia. Commun.Dis.Intell. 
22:249-252. 
 17.  Bell, J. M., J. C. Paton, and J. Turnidge. 1998. Emergence of vancomycin-resistant 
enterococci in Australia: Phenotypic and genotypic characteristics of isolates. 
J.Clin.Microbiol. 36:2187-2190. 
 18.  Bellanger, X., A. P. Roberts, C. Morel, F. Choulet, G. Pavlovic, P. Mullany, B. 
Decaris, and G. Guedon. 2009. Conjugative transfer of the Integrative Conjugative 
Elements ICESt1 and ICESt3 from Streptococcus thermophilus. J.Bacteriol. 
191:2764-2775. 
 19.  Bertram, J., M. Stratz, and P. Durre. 1991. Natural transfer of conjugative 
transposon Tn916 between gram-positive and gram-negative bacteria. J.Bacteriol. 
173:443-448. 
 20.  Biavasco, F., G. Foglia, C. Paoletti, G. Zandri, G. Magi, E. Guaglianone, A. 
Sundsfjord, C. Pruzzo, G. Donelli, and B. Facinelli. 2007. VanA-type enterococci 
from humans, animals, and food: species distribution, population structure, Tn1546 
typing and location, and virulence determinants. Appl.Environ.Microbiol. 73:3307-
3319. 
 21.  Björholt, I. and E. Haglind. 2004. Cost-savings achieved by eradication of epidemic 
methicillin-resistant Staphylococcus aureus (EMRSA)-16 from a large teaching 
hospital. European Journal of Clinical Microbiology & Infectious Diseases 23:688-
695. 
 22.  Bonora, M. G., M. Ligozzi, F. M. De, L. Bragagnolo, A. Goglio, G. C. Guazzotti, 
and R. Fontana. 2004. Vancomycin-resistant Enterococcus faecium isolates causing 
hospital outbreaks in northern Italy belong to the multilocus sequence typing C1 
lineage. Microb.Drug Resist. 10:114-123. 
 23.  Bonora, M. G., M. Solbiati, E. Stepan, A. Zorzi, A. Luzzani, M. R. Catania, and 
R. Fontana. 2006. Emergence of linezolid resistance in the vancomycin-resistant 
Enterococcus faecium multilocus sequence typing C1 epidemic lineage. J 
Clin.Microbiol. 44:1153-1155. 
 24.  Bonten, M. J., R. Willems, and R. A. Weinstein. 2001. Vancomycin-resistant 
enterococci: why are they here, and where do they come from? The Lancet Infectious 
Diseases 1:314-325.  
Ph.D Thesis, 2010  Bjørkeng, EK. 
 54
 25.  Bourgogne, A., D. A. Garsin, X. Qin, K. V. Singh, J. Sillanpaa, S. Yerrapragada, 
Y. Ding, S. Dugan-Rocha, C. Buhay, H. Shen, G. Chen, G. Williams, D. Muzny, 
A. Maadani, K. A. Fox, J. Gioia, L. Chen, Y. Shang, C. A. Arias, S. R. 
Nallapareddy, M. Zhao, V. P. Prakash, S. Chowdhury, H. Jiang, R. A. Gibbs, B. 
E. Murray, S. K. Highlander, and G. M. Weinstock. 2008. Large scale variation in 
Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome 
Biol. 9:R110. 
 26.  Bourgoin, F., G. Guedon, M. Pebay, Y. Roussel, C. Panis, and B. Decaris. 1996. 
Characterization of a mosaic ISS1 element and evidence for the recent horizontal 
transfer of two different types of ISS1 between Streptococcus thermophilus and 
Lactococcus lactis. Gene 178:15-23. 
 27.  Boyce, J. M., G. Potter-Bynoe, C. Chenevert, and T. King. 1997. Environmental 
contamination due to methicillin-resistant Staphylococcus aureus: possible infection 
control implications. Infect.Control Hosp.Epidemiol. 18:622-627. 
 28.  Bradley, C. R. and A. P. Fraise. 1996. Heat and chemical resistance of enterococci. J 
Hosp.Infect. 34:191-196. 
 29.  Brandis, H., P. Pleceas, and L. Andries. 1985. Typing of Streptococcus faecalis and 
Streptococcus faecium strains with bacteriophages. 
Zentralbl.Bakteriol.Mikrobiol.Hyg.A 260:206-215. 
 30.  Braun, V., M. Mehlig, M. Moos, M. Rupnik, B. Kalt, D. E. Mahony, and C. von 
Eichel-Streiber. 2000. A chimeric ribozyme in clostridium difficile combines features 
of group I introns and insertion elements. Mol.Microbiol. 36:1447-1459.  
 31.  Brochet, M., E. Couve, P. Glaser, G. Guedon, and S. Payot. 2008. Integrative 
conjugative elements and related elements are major contributors to the genome 
diversity of Streptococcus agalactiae. J Bacteriol. 190:6913-6917. 
 32.  Brochet, M., C. Da, V, E. Couve, C. Rusniok, P. Trieu-Cuot, and P. Glaser. 2009. 
Atypical association of DDE transposition with conjugation specifies a new family of 
mobile elements. Mol.Microbiol. 
 33.  Brochet, M., C. Rusniok, E. Couve, S. Dramsi, C. Poyart, P. Trieu-Cuot, F. 
Kunst, and P. Glaser. 2008. Shaping a bacterial genome by large chromosomal 
replacements, the evolutionary history of Streptococcus agalactiae. 
Proc.Natl.Acad.Sci.U.S.A 105:15961-15966. 
 34.  Bruand, C., S. D. Ehrlich, and L. Janniere. 1991. Unidirectional theta replication of 
the structurally stable Enterococcus faecalis plasmid pAM beta 1. EMBO J. 10:2171-
2177. 
 35.  Burrus, V., G. Pavlovic, B. Decaris, and G. Guedon. 2002. Conjugative 
transposons: the tip of the iceberg. Mol.Microbiol. 46:601-610. 
 36.  Caillaud, F., C. Carlier, and P. Courvalin. 1987. Physical analysis of the 
conjugative shuttle transposon Tn1545. Plasmid 17:58-60.  
Ph.D Thesis, 2010  Bjørkeng, EK. 
 55
 37.  Carmeli, Y., G. M. Eliopoulos, and M. H. Samore. 2002. Antecedent treatment with 
different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. 
Emerg.Infect.Dis. 8:802-807. 
 38.  Carrico, J. A., F. R. Pinto, C. Simas, S. Nunes, N. G. Sousa, N. Frazao, H. de 
Lencastre, and J. S. Almeida. 2005. Assessment of band-based similarity 
coefficients for automatic type and subtype classification of microbial isolates 
analyzed by pulsed-field gel electrophoresis. J.Clin.Microbiol. 43:5483-5490. 
 39.  Chopin, A., A. Bolotin, A. Sorokin, S. D. Ehrlich, and M. C. Chopin. 2001. 
Analysis of six prophages in Lactococcus lactis IL1403: different genetic structure of 
temperate and virulent phage populations. Nucl.Acids Res. 29:644-651. 
 40.  Chopin, M. C., A. Chopin, and E. Bidnenko. 2005. Phage abortive infection in 
lactococci: variations on a theme. Curr.Opin.Microbiol. 8:473-479.  
 41.  Christensen, S. K., M. Mikkelsen, K. Pedersen, and K. Gerdes. 2001. RelE, a 
global inhibitor of translation, is activated during nutritional stress. 
Proc.Natl.Acad.Sci.U.S.A 98:14328-14333. d 
 42.  Christensen, S. K., K. Pedersen, F. G. Hansen, and K. Gerdes. 2003. Toxin-
antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated 
RNAs and are counteracted by tmRNA. J.Mol.Biol. 332:809-819.  
 43.  Clewell, D. B., S. E. Flannagan, D. D. Jaworski, and D. B. Clewell. 1995. 
Unconstrained bacterial promiscuity: the Tn916-Tn1545 family of conjugative 
transposons. Trends in Microbiology 3:229-236.  
 44.  Clewell, D. B., Victoria F.M., S. E. Flannagan, and F. Y. An. 2002. Enterococcal 
plasmid transfer: sex pheromones, transfer origins, relaxases, and the Staphylococcus 
aureus issue. Plasmid 48:193-201.  
 45.  Coque, T. M., R. J. Willems, J. Fortun, J. Top, S. Diz, E. Loza, R. Canton, and F. 
Baquero. 2005. Population structure of Enterococcus faecium causing bacteremia in a 
Spanish university hospital: setting the scene for a future increase in vancomycin 
resistance? Antimicrob.Agents Chemother. 49:2693-2700. 
 46.  Cosgrove, S. E., G. Sakoulas, E. N. Perencevich, M. Schwaber, A. W. Karchmer, 
and Y. Carmeli. 2003. Comparison of Mortality Associated with Methicillin 
Resistant and Methicillin Susceptible Staphylococcus aureus Bacteremia: A Meta 
analysis. Clinical Infectious Diseases 36:53-59. 
 47.  Courvalin, P. 2006. Vancomycin resistance in gram-positive cocci. Clin.Infect.Dis. 
42 Suppl 1:S25-S34. 
 48.  Craig, N. L., R. Craigie, M. Gellert, and A. M. Lambowitz. 2002. Mobile DNA II. 
ASM press, Washington. 
 49.  Craig, N. L. 1997. Target site selection in transposition. Annu.Rev Biochem. 66:437-
474. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 56
 50.  Currie, B. P. and L. Lemos-Filho. 2004. Evidence for Biliary Excretion of 
Vancomycin into Stool during Intravenous Therapy: Potential Implications for Rectal 
Colonization with Vancomycin-Resistant Enterococci. Antimicrob.Agents Chemother. 
48:4427-4429. 
 51.  Dahl, K. H., E. W. Lundblad, T. P. Rokenes, O. Olsvik, and A. Sundsfjord. 2000. 
Genetic linkage of the vanB2 gene cluster to Tn5382 in vancomycin-resistant 
enterococci and characterization of two novel insertion sequences. Microbiology 146 ( 
Pt 6):1469-1479. 
 52.  Dahl, K. H., D. D. Mater, M. J. Flores, P. J. Johnsen, T. Midtvedt, G. Corthier, 
and A. Sundsfjord. 2007. Transfer of plasmid and chromosomal glycopeptide 
resistance determinants occurs more readily in the digestive tract of mice than in vitro 
and exconjugants can persist stably in vivo in the absence of glycopeptide selection. J 
Antimicrob.Chemother. 59:478-486. 
 53.  Dahl, K. H., G. S. Simonsen, O. Olsvik, and A. Sundsfjord. 1999. Heterogeneity in 
the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant 
enterococci. Antimicrob.Agents Chemother. 43:1105-1110. 
 54.  Dahl, K. H. and A. Sundsfjord. 2003. Transferable vanB2 Tn5382-containing 
elements in fecal streptococcal strains from veal calves. Antimicrob.Agents 
Chemother. 47:2579-2583. 
 55.  Dahl, KH., TP. Rokenes, EW. Lundblad, and A. Sundsfjord. 2003. 
Nonconjugative Transposition of the vanB-Containing Tn5382-Like Element in 
Enterococcus faecium. Antimicrob.Agents Chemother. 47:786-789. 
 56.  Damborg, P., A. H. Sorensen, and L. Guardabassi. 2008. Monitoring of 
antimicrobial resistance in healthy dogs: first report of canine ampicillin-resistant 
Enterococcus faecium clonal complex 17. Vet.Microbiol. 132:190-196.  
 57.  Damborg, P., J. Top, A. P. Hendrickx, S. Dawson, R. J. Willems, and L. 
Guardabassi. 2009. Dogs are a reservoir of ampicillin-resistant Enterococcus faecium 
lineages associated with human infections. Appl.Environ.Microbiol. 75:2360-2365. 
 58.  Davies, M. R., J. Shera, G. H. Van Domselaar, K. S. Sriprakash, and D. J. 
McMillan. 2009. A novel integrative conjugative element mediates genetic transfer 
from group G Streptococcus to other beta-hemolytic Streptococci. J.Bacteriol. 
191:2257-2265.  
 59.  de la Cruz, F. and J. Davies. 2000. Horizontal gene transfer and the origin of species: 
lessons from bacteria. Trends in Microbiology 8:128-133.  
 60.  De Leener, E., A. Mel, E. M. De Graef, J. Top, P. Butaye, F. Haesebrouck, R. 
Willems, and A. Decostere. 2005. Molecular analysis of human, porcine, and poultry 
Enterococcus faecium isolates and their erm(B) genes. Appl.Environ.Microbiol. 
71:2766-2770.  
 61.  Demertzi, E., M. F. Palepou, M. E. Kaufmann, A. Avlamis, and N. Woodford. 
2001. Characterisation of vanA and vanB elements from glycopeptide-resistant 
Enterococcus faecium from Greece. J.Med.Microbiol. 50:682-687. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 57
 62.  Deurenberg, R. H. and E. E. Stobberingh. 2008. The evolution of Staphylococcus 
aureus. Infection, Genetics and Evolution 8:747-763. 
 63.  Devriese, L. A., B. Pot, and M. D. Collins. 1993. Phenotypic identification of the 
genus Enterococcus and differentiation of phylogenetically distinct enterococcal 
species and species groups. J Appl.Bacteriol 75:399-408. 
 64.  Domingo, M. C., A. Huletsky, A. Bernal, R. Giroux, D. K. Boudreau, F. J. Picard, 
and M. G. Bergeron. 2005. Characterization of a Tn5382-like transposon containing 
the vanB2 gene cluster in a Clostridium strain isolated from human faeces. J 
Antimicrob.Chemother. 55:466-474. 
 65.  Domingo, M. C., A. Huletsky, R. Giroux, K. Boissinot, F. J. Picard, P. Lebel, M. 
J. Ferraro, and M. G. Bergeron. 2005. High prevalence of glycopeptide resistance 
genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. 
Antimicrob.Agents Chemother. 49:4784-4786. 
 66.  Donskey, C.-J., J.-A. Hanrahan, R.-A. Hutton, and L.-B. Rice. 1999. Effect of 
parenteral antibiotic administration on persistence of vancomycin−resistant 
Enterococcus faecium in the mouse gastrointestinal tract. The Journal of Infectious 
Diseases 180:384-390. 
 67.  Eaton, T. J. and M. J. Gasson. 2001. Molecular screening of Enterococcus virulence 
determinants and potential for genetic exchange between food and medical isolates. 
Appl.Environ.Microbiol 67:1628-1635. 
 68.  Edlund, C., L. Barkholt, B. Olsson-Liljequist, and C. E. Nord. 1997. Effect of 
vancomycin on intestinal flora of patients who previously received antimicrobial 
therapy. Clin.Infect.Dis. 25:729-732. 
 69.  Embil, J. M., J. A. McLeod, A. M. Al-Barrak, G. M. Thompson, F. Y. Aoki, E. J. 
Witwicki, M. F. Stranc, A. M. Kabani, D. R. Nicoll, and L. E. Nicolle. 2001. An 
outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role 
of contaminated hydrotherapy equipment. Burns 27:681-688.  
 70.  Engel, H. W., N. Soedirman, J. A. Rost, W. J. van Leeuwen, and J. D. van 
Embden. 1980. Transferability of macrolide, lincomycin, and streptogramin 
resistances between group A, B, and D streptococci, Streptococcus pneumoniae, and 
Staphylococcus aureus. J.Bacteriol. 142:407-413. 
 71.  EuropeanCommittee forAntimicrobial SusceptibilityTesting (EUCAST) of the 
European Society of ClinicalMicrobiology and InfectiousDiseases (ESCMID). 
Terminology relating to methods for the determination of susceptibility 
  of bacteria to antimicrobial agents.  2000.  
 
 72.  Facklam, R. 2002. What happened to the streptococci: overview of taxonomic and 
nomenclature changes. Clin.Microbiol.Rev. 15:613-630. 
 73.  Falk, P. G., L. V. Hooper, T. Midtvedt, and J. I. Gordon. 1998. Creating and 
maintaining the gastrointestinal ecosystem: what we know and need to know from 
gnotobiology. Microbiol.Mol.Biol.Rev 62:1157-1170. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 58
 74.  Fang, H., C. E. Nord, and M. Ullberg. 2010. Screening for vancomycin-resistant 
enterococci: results of a survey in Stockholm. APMIS 118:413-417. 
 75.  Fisher, K. and C. Phillips. 2009. The ecology, epidemiology and virulence of 
Enterococcus. Microbiology. 
 76.  Flores, M., P. Mavingui, X. Perret, W. J. Broughton, D. Romero, G. Hernàndez, 
G. Dàvila, and R. Palacios. 2000. Prediction, identification, and artificial selection of 
DNA rearrangements in Rhizobium: Toward a natural genomic design. Proceedings of 
the National Academy of Sciences of the United States of America 97:9138-9143. 
 77.  Fox.JL. DOE Joint Genome Institute feat: One-day sequencing of E. faecium. ASM 
News 66, 388. 2000.  
 
 78.  Franke, A. E. and D. B. Clewell. 1981. Evidence for a chromosome-borne resistance 
transposon (Tn916) in Streptococcus faecalis that is capable of "conjugal" transfer in 
the absence of a conjugative plasmid. J Bacteriol. 145:494-502. 
 79.  Franz, C. M., W. H. Holzapfel, and M. E. Stiles. 1999. Enterococci at the 
crossroads of food safety? Int.J Food Microbiol. 47:1-24. 
 80.  Freeman, R., A. M. Kearns, and N. F. Lightfoot. 1994. Heat resistance of 
nosocomial enterococci. The Lancet 344:64-65. 
 81.  Freitas, A. R., C. Novais, P. Ruiz-Garbajosa, T. M. Coque, and L. Peixe. 2009. 
Dispersion of multidrug-resistant Enterococcus faecium isolates belonging to major 
clonal complexes in different portuguese settings. Appl.Environ.Microbiol. 75:4904-
4908. 
 82.  Freitas, A. R., A. P. Tedim, C. Novais, P. Ruiz-Garbajosa, G. Werner, J. A. 
Laverde-Gomez, R. Canton, L. Peixe, F. Baquero, and T. M. Coque. 2010. Global 
spread of the hylEfm colonization-virulence gene in megaplasmids of the 
Enterococcus faecium CC17 polyclonal subcluster. Antimicrob.Agents Chemother. 
54:2660-2665. 
 83.  Frieden, T. R., S. S. Munsiff, D. E. Low, B. M. Willey, G. Williams, Y. Faur, W. 
Eisner, S. Warren, and B. Kreiswirth. 1993. Emergence of vancomycin-resistant 
enterococci in New York City. Lancet 342:76-79. 
 84.  Frost, L. S., R. Leplae, A. O. Summers, and A. Toussaint. 2005. Mobile genetic 
elements: the agents of open source evolution. Nat Rev Micro 3:722-732.  
 85.  Galloway-Pena, J. R., S. R. Nallapareddy, C. A. Arias, G. M. Eliopoulos, and B. 
E. Murray. 2009. Analysis of clonality and antibiotic resistance among early clinical 
isolates of Enterococcus faecium in the United States. J Infect.Dis. 200:1566-1573. 
 86.  Garnier, F., S. Taourit, P. Glaser, P. Courvalin, and M. Galimand. 2000. 
Characterization of transposon Tn1549, conferring VanB-type resistance in 
Enterococcus spp. Microbiology 146:1481-1489. 
 87.  Garriss, G., M. K. Waldor, and V. Burrus. 2009. Mobile antibiotic resistance 
encoding elements promote their own diversity. PLoS.Genet. 5:e1000775.  
Ph.D Thesis, 2010  Bjørkeng, EK. 
 59
 88.  Gastmeier, P., D. Sohr, C. Geffers, M. Behnke, F. Daschner, and H. Rüden. 2005. 
Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive 
care units: Results from the German Nosocomial Infection Surveillance System 
(KISS). Infection 33:50-55.  
 89.  Ghigo, J. M. 2001. Natural conjugative plasmids induce bacterial biofilm 
development. Nature 412:442-445. 
 90.  Goodrich-Blair, H., V. Scarlato, J. M. Gott, M. Q. Xu, and D. A. Shub. 1990. A 
self-splicing group I intron in the DNA polymerase gene of Bacillus subtilis 
bacteriophage SPO1. Cell 63:417-424. 
 91.  Grady, R. and F. Hayes. 2003. Axe-Txe, a broad-spectrum proteic toxin-antitoxin 
system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. 
Mol.Microbiol. 47:1419-1432. 
 92.  Graham, M., S. A. Ballard, E. A. Grabsch, P. D. Johnson, and M. L. Grayson. 
2008. High rates of fecal carriage of nonenterococcal vanB in both children and adults. 
Antimicrob.Agents Chemother. 52:1195-1197. 
 93.  Granlund, M., C. Carlsson, H. Edebro, K. Emanuelsson, and R. Lundholm. 2006. 
Nosocomial outbreak of vanB2 vancomycin-resistant Enterococcus faecium in 
Sweden. J Hosp.Infect. 62:254-256. 
 94.  Grohmann, E., G. Muth, and M. Espinosa. 2003. Conjugative plasmid transfer in 
gram-positive bacteria. Microbiol.Mol.Biol.Rev 67:277-301, table. 
 95.  Guskey, M. T. and B. T. Tsuji. 2010. A comparative review of the 
lipoglycopeptides: oritavancin, dalbavancin, and telavancin. Pharmacotherapy 30:80-
94. 
 96.  Haaber, J., G. M. Rousseau, K. Hammer, and S. Moineau. 2009. Identification and 
characterization of the phage gene sav, involved in sensitivity to the lactococcal 
abortive infection mechanism AbiV. Appl.Environ.Microbiol. 75:2484-2494.  
 97.  Hacker, J. and E. Carniel. 2001. Ecological fitness, genomic islands and bacterial 
pathogenicity. A Darwinian view of the evolution of microbes. EMBO Rep. 2:376-
381. 
 98.  Hamilton-Miller, J. M. T. 1988. Reversal of activity of trimethoprim against Gram-
positive cocci by thymidine, thymine and 'folates'. J.Antimicrob.Chemother. 22:35-39. 
 99.  Hanage, W. P., C. Fraser, and B. G. Spratt. 2006. The impact of homologous 
recombination on the generation of diversity in bacteria. J Theor.Biol. 239:210-219. 
 100.  Hanrahan, J., C. Hoyen, and L. B. Rice. 2000. Geographic distribution of a large 
mobile element that transfers ampicillin and vancomycin resistance between 
Enterococcus faecium strains. Antimicrob.Agents Chemother. 44:1349-1351. 
 101.  Hanssen, A. M., G. Kjeldsen, and J. U. E. Sollid. 2004. Local variants of 
staphylococcal cassette chromosome mec in sporadic methicillin-resistant 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 60
Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci: 
Evidence of horizontal gene transfer? Antimicrob.Agents Chemother. 48:285-296. 
 102.  Harbarth, S., S. Cosgrove, and Y. Carmeli. 2002. Effects of antibiotics on 
nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob.Agents 
Chemother. 46:1619-1628. 
 103.  Hardie, J. M. and R. A. Whiley. 1997. Classification and overview of the genera 
Streptococcus and Enterococcus. Soc.Appl.Bacteriol Symp.Ser. 26:1S-11S. 
 104.  Harthug, S., A. Digranes, O. Hope, B. E. Kristiansen, A. G. Allum, and N. 
Langeland. 2000. Vancomycin resistance emerging in a clonal outbreak caused by 
ampicillin-resistant Enterococcus faecium. Clin.Microbiol Infect. 6:19-28. 
 105.  Hayes, F. 2003. Toxins-antitoxins: plasmid maintenance, programmed cell death, and 
cell cycle arrest. Science 301:1496-1499. 
 106.  Hegstad, K., T. Mikalsen, T. M. Coque, G. Werner, and A. Sundsfjord. 2010. 
Mobile genetic elements and their contribution to the emergence of antimicrobial 
resistant Enterococcus faecalis and Enterococus faecium. Clin.Microbiol.Infect. 
16:541-554. 
 107.  Heikens, E., M. J. Bonten, and R. J. Willems. 2007. Enterococcal surface protein 
Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 
189:8233-8240. 
 108.  Hendrickx, A. P. A., W. J. B. van Wamel, G. Posthuma, M. J. M. Bonten, and R. 
J. L. Willems. 2007. Five geneseEncoding surface-exposed LPXTG proteins are 
enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates. 
J.Bacteriol. 189:8321-8332. 
 109.  Hendrickx, A. P., M. J. Bonten, M. van Luit-Asbroek, C. M. Schapendonk, A. H. 
Kragten, and R. J. Willems. 2008. Expression of two distinct types of pili by a 
hospital-acquired Enterococcus faecium isolate. Microbiology 154:3212-3223.  
 110.  Hendrickx, A. P., M. van Luit-Asbroek, C. M. Schapendonk, W. J. van Wamel, J. 
C. Braat, L. M. Wijnands, M. J. Bonten, and R. J. Willems. 2009. SgrA, a 
nidogen-binding LPXTG surface adhesin implicated in biofilm formation, and EcbA, 
a collagen binding MSCRAMM, are two novel adhesins of hospital-acquired 
Enterococcus faecium. Infect.Immun. 77:5097-5106. 
 111.  Heuer, H., Z. Abdo, and K. Smalla. 2008. Patchy distribution of flexible genetic 
elements in bacterial populations mediates robustness to environmental uncertainty. 
FEMS Microbiol.Ecol. 65:361-371. 
 112.  Hiramatsu, K., L. Cui, M. Kuroda, and T. Ito. 2001. The emergence and evolution 
of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9:486-493. 
 113.  Hoess, R. H. and A. Landy. 1978. Structure of the lambda att sites generated by int-
dependent deletions. Proc.Natl.Acad.Sci.U.S.A 75:5437-5441. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 61
 114.  Holden, M. T., H. Hauser, M. Sanders, T. H. Ngo, I. Cherevach, A. Cronin, I. 
Goodhead, K. Mungall, M. A. Quail, C. Price, E. Rabbinowitsch, S. Sharp, N. J. 
Croucher, T. B. Chieu, N. T. Mai, T. S. Diep, N. T. Chinh, M. Kehoe, J. A. Leigh, 
P. N. Ward, C. G. Dowson, A. M. Whatmore, N. Chanter, P. Iversen, M. 
Gottschalk, J. D. Slater, H. E. Smith, B. G. Spratt, J. Xu, C. Ye, S. Bentley, B. G. 
Barrell, C. Schultsz, D. J. Maskell, and J. Parkhill. 2009. Rapid evolution of 
virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. 
PLoS.One. 4:e6072.  
 115.  Homan, WL., D. Tribe, S. Poznanski, M. Li, G. Hogg, E. Spalburg, J. van 
Embden, and R. Willems. 2002. Multilocus Sequence Typing Scheme for 
Enterococcus faecium. J.Clin.Microbiol. 40:1963-1971. 
 116.  Horodniceanu, T., L. Bougueleret, N. El-Solh, G. Bieth, and F. Delbos. 1979. 
High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. 
zymogenes. Antimicrob.Agents Chemother. 16:686-689. 
 117.  Hyman, P. and S. T. Abedon. 2010. Bacteriophage host range and bacterial 
resistance. Adv.Appl.Microbiol. 70:217-248. 
 118.  Iversen, A., I. Kuhn, A. Franklin, and R. Mollby. 2002. High prevalence of 
vancomycin-resistant enterococci in Swedish sewage. Appl.Environ.Microbiol. 
68:2838-2842. 
 119.  Jensen, L. B., L. Garcia-Migura, A. J. Valenzuela, M. Lohr, H. Hasman, and F. 
M. Aarestrup. 2010. A classification system for plasmids from enterococci and other 
Gram-positive bacteria. J.Microbiol.Methods 80:25-43.  
 120.  Jett, B. D., M. M. Huycke, and M. S. Gilmore. 1994. Virulence of enterococci. 
Clin.Microbiol.Rev. 7:462-478. 
 121.  Jones, D. 1978. Composition and differentiation of the genus Streptococcus. 
Soc.Appl.Bacteriol.Symp.Ser. 7:1-49. 
 122.  Juhas, M., d. M. van, Jr., M. Gaillard, R. M. Harding, D. W. Hood, and D. W. 
Crook. 2008. Genomic islands: tools of bacterial horizontal gene transfer and 
evolution. FEMS Microbiol.Rev. 
 123.  Kahlmeter, G., D. F. J. Brown, F. W. Goldstein, A. P. MacGowan, J. W. Mouton, 
A. Osterlund, A. Rodloff, M. Steinbakk, P. Urbaskova, and A. Vatopoulos. 2003. 
European harmonization of MIC breakpoints for antimicrobial susceptibility testing of 
bacteria. J.Antimicrob.Chemother. 52:145-148. 
 124.  Kasparek, P., R. Pantucek, J. Kahankova, V. Ruzickova, and J. Doskar. 2007. 
Genome rearrangements in host-range mutants of the polyvalent staphylococcal 
bacteriophage 812. Folia Microbiol.(Praha) 52:331-338. 
 125.  Katayama, Y., F. Takeuchi, T. Ito, X. X. Ma, Y. Ui-Mizutani, I. Kobayashi, and 
K. Hiramatsu. 2003. Identification in methicillin-susceptible Staphylococcus hominis 
of an active primordial mobile genetic element for the staphylococcal cassette 
chromosome mec of methicillin-resistant Staphylococcus aureus. J.Bacteriol. 
185:2711-2722. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 62
 126.  Katayama, Y., T. Ito, and K. Hiramatsu. 2000. A New Class of Genetic Element, 
Staphylococcus Cassette Chromosome mec, Encodes Methicillin Resistance in 
Staphylococcus aureus. Antimicrob.Agents Chemother. 44:1549-1555. 
 127.  Kearns, A. M., R. Freeman, and N. F. Lightfoot. 1995. Nosocomial enterococci: 
resistance to heat and sodium hypochlorite. J Hosp.Infect. 30:193-199. 
 128.  Khan, M. A., W. M. van der, D. J. Farrell, L. Cossins, A. van Belkum, A. 
Alaidan, and J. P. Hays. 2008. Analysis of VanA vancomycin-resistant Enterococcus 
faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 
and two new Tn1546 lineage types. J Antimicrob.Chemother. 62:279-283. 
 129.  Kim, D. S., K. V. Singh, S. R. Nallapareddy, X. Qin, D. Panesso, C. A. Arias, and 
B. E. Murray. 2010. The fms21 (pilA)-fms20 locus encoding one of four distinct pili 
of Enterococcus faecium is harboured on a large transferable plasmid associated with 
gut colonization and virulence. J Med Microbiol 59:505-507. 
 130.  Klare, I., C. Konstabel, S. Mueller-Bertling, G. Werner, B. Strommenger, C. 
Kettlitz, S. Borgmann, B. Schulte, D. Jonas, A. Serr, A. M. Fahr, U. Eigner, and 
W. Witte. 2005. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of 
the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German 
hospitals. Eur.J Clin.Microbiol.Infect.Dis. 24:815-825. 
 131.  Klare, I., G. Werner, and W. Witte. 2001. Enterococcci. Habitatis, Infections, 
virulence factors, Resistances to Antibiotics, Transfer of Resistance Determinants, p. 
108-122. In: Muhldorfer Inge and Schafer Klaus P (eds.), Emerging Bacterial 
Pathogens. vol8 ed. Karger. 
 132.  Klein, G. 2003. Taxonomy, ecology and antibiotic resistance of enterococci from food 
and the gastro-intestinal tract. International Journal of Food Microbiology 88:123-131. 
 133.  Ko, K. S., J. Y. Baek, J. Y. Lee, W. S. Oh, K. R. Peck, N. Y. Lee, W. G. Lee, K. 
Lee, and J. H. Song. 2005. Molecular Characterization of Vancomycin-Resistant 
Enterococcus faecium Isolates from Korea. J.Clin.Microbiol. 43:2303-2306. 
 134.  Koh, T. H., L. Y. Hsu, L. L. Chiu, and R. V. Lin. 2006. Emergence of epidemic 
clones of vancomycin-resistant Enterococcus faecium in Singapore. J Hosp.Infect. 
63:234-236. 
 135.  Kuduvalli, P. N., J. E. Rao, and N. L. Craig. 2001. Target DNA structure plays a 
critical role in Tn7 transposition. EMBO J 20:924-932. 
 136.  Kuhn, I., A. Iversen, L. G. Burman, B. Olsson-Liljequist, A. Franklin, M. Finn, F. 
Aarestrup, A. M. Seyfarth, A. R. Blanch, X. Vilanova, H. Taylor, J. Caplin, M. A. 
Moreno, L. Dominguez, I. A. Herrero, and R. Mollby. 2003. Comparison of 
enterococcal populations in animals, humans, and the environment a European study. 
Int.J Food Microbiol. 88:133-145. 
 137.  Kurokawa, K., T. Itoh, T. Kuwahara, K. Oshima, H. Toh, A. Toyoda, H. Takami, 
H. Morita, V. K. Sharma, T. P. Srivastava, T. D. Taylor, H. Noguchi, H. Mori, Y. 
Ogura, D. S. Ehrlich, K. Itoh, T. Takagi, Y. Sakaki, T. Hayashi, and M. Hattori. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 63
2007. Comparative metagenomics revealed commonly enriched gene sets in human 
gut microbiomes. DNA Res. 14:169-181. 
 138.  Launay, A., SA. Ballard, P. Johnson, M. Grayson, and T. Lambert. 2006. Transfer 
of Vancomycin Resistance Transposon Tn1549 from Clostridium symbiosum to 
Enterococcus spp. in the Gut of Gnotobiotic Mice. Antimicrob.Agents Chemother. 
50:1054-1062. 
 139.  Leavis, H., J. Top, N. Shankar, K. Borgen, M. Bonten, J. van Embden, and R. J. 
L. Willems. 2004. A Novel Putative Enterococcal Pathogenicity Island Linked to the 
esp Virulence Gene of Enterococcus faecium and Associated with Epidemicity. 
J.Bacteriol. 186:672-682. 
 140.  Leavis, H. L., M. J. Bonten, and R. J. Willems. 2006. Identification of high-risk 
enterococcal clonal complexes: global dispersion and antibiotic resistance. 
Curr.Opin.Microbiol. 9:454-460. 
 141.  Leavis, H. L., R. J. Willems, J. Top, E. Spalburg, E. M. Mascini, A. C. Fluit, A. 
Hoepelman, A. J. de Neeling, and M. J. Bonten. 2003. Epidemic and nonepidemic 
multidrug-resistant Enterococcus faecium. Emerg.Infect.Dis. 9:1108-1115. 
 142.  Leclercq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated 
resistance to vancomycin and teicoplanin in Enterococcus faecium. N.Engl.J Med. 
319:157-161. 
 143.  Leendertse, M., E. Heikens, L. M. Wijnands, M. van Luit-Asbroek, G. J. Teske, 
J. J. Roelofs, M. J. Bonten, T. van der Poll, and R. J. Willems. 2009. Enterococcal 
surface protein transiently aggravates Enterococcus faecium-induced urinary tract 
infection in mice. J.Infect.Dis. 200:1162-1165.  
 144.  Lefort, A., A. Saleh-Mghir, L. Garry, C. Carbon, and B. Fantin. 2000. Activity of 
LY333328 Combined with Gentamicin In Vitro and in Rabbit Experimental 
Endocarditis Due to Vancomycin-Susceptible or -Resistant Enterococcus faecalis. 
Antimicrob.Agents Chemother. 44:3017-3021. 
 145.  Lester, C. H., D. Sandvang, S. S. Olsen, H. C. Schonheyder, J. O. Jarlov, J. 
Bangsborg, D. S. Hansen, T. G. Jensen, N. Frimodt-Moller, and A. M. 
Hammerum. 2008. Emergence of ampicillin-resistant Enterococcus faecium in 
Danish hospitals. J Antimicrob.Chemother. 62:1203-1206. 
 146.  Lett, M. C. 1988. Tn3-like elements: molecular structure, evolution. Biochimie 
70:167-176.  
 147.  Levy, S. B. 1992. The antibiotic paradox. Plenum Press, New York. 
 148.  Li, Y. H., P. C. Y. Lau, J. H. Lee, R. P. Ellen, and D. G. Cvitkovitch. 2001. Natural 
Genetic Transformation of Streptococcus mutans Growing in Biofilms. J.Bacteriol. 
183:897-908. 
 149.  Libisch, B., Z. Lepsanovic, J. Top, M. Muzslay, M. Konkoly-Thege, M. Gacs, B. 
Balogh, M. Fuzi, and R. J. Willems. 2008. Molecular characterization of 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 64
vancomycin-resistant Enterococcus spp. clinical isolates from Hungary and Serbia. 
Scand.J Infect.Dis. 40:778-784. 
 150.  Lopez, M., J. C. Hormazabal, A. Maldonado, G. Saavedra, F. Baquero, J. Silva, 
C. Torres, and C. R. Del. 2009. Clonal dissemination of Enterococcus faecalis 
ST201 and Enterococcus faecium CC17-ST64 containing Tn5382-vanB2 among 16 
hospitals in Chile. Clin.Microbiol.Infect. 15:586-588. 
 151.  Lorenzo-Diaz, F., T. Delgado, J. A. Reyes-Darias, C. Flores, S. Mendez-Alvarez, 
J. Villar, A. Sierra, and F. Claverie-Martin. 2004. Characterization of the first 
VanB vancomycin-resistant Enterococcus faecium isolated in a Spanish hospital. 
Curr.Microbiol. 48:199-203. 
 152.  Lu, J. J., T. Y. Chang, C. L. Perng, and S. Y. Lee. 2005. The vanB2 Gene Cluster of 
the Majority of Vancomycin-Resistant Enterococcus faecium Isolates from Taiwan Is 
Associated with the pbp5 Gene and Is Carried by Tn5382 Containing a Novel 
Insertion Sequence. Antimicrob.Agents Chemother. 49:3937-3939. 
 153.  Maiden, M. C., J. A. Bygraves, E. Feil, G. Morelli, J. E. Russell, R. Urwin, Q. 
Zhang, J. Zhou, K. Zurth, D. A. Caugant, I. M. Feavers, M. Achtman, and B. G. 
Spratt. 1998. Multilocus sequence typing: a portable approach to the identification of 
clones within populations of pathogenic microorganisms. Proc.Natl.Acad.Sci.U.S.A 
95:3140-3145. 
 154.  Maiques, E., C. Ubeda, M. A. Tormo, M. D. Ferrer, I. Lasa, R. P. Novick, and J. 
R. Penades. 2007. Role of staphylococcal phage and SaPI integrase in intra- and 
interspecies SaPI transfer. J Bacteriol 189:5608-5616. 
 155.  Manson, J. M., L. E. Hancock, and M. S. Gilmore. 2010. Mechanism of 
chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule, 
antimicrobial resistance, and other traits. Proc.Natl.Acad.Sci.U.S.A. 107:12269-
12274. 
 156.  Marraffini, L. A. and E. J. Sontheimer. 2008. CRISPR interference limits horizontal 
gene transfer in staphylococci by targeting DNA. Science 322:1843-1845. 
 157.  Martinez, J. L. 2008. Antibiotics and Antibiotic Resistance Genes in Natural 
Environments. Science 321:365-367. 
 158.  McBride, S. M., P. S. Coburn, A. S. Baghdayan, R. J. Willems, M. J. Grande, N. 
Shankar, and M. S. Gilmore. 2009. Genetic variation and evolution of the 
pathogenicity island of Enterococcus faecalis. J Bacteriol 191:3392-3402. 
 159.  McGregor, K. F., C. Nolan, H. K. Young, M. F. Palepou, L. Tysall, and N. 
Woodford. 2001. Prevalence of the vanB2 gene cluster in vanB glycopeptide-resistant 
enterococci in the United Kingdom and the Republic of Ireland and its association 
with a Tn5382-like element. Antimicrob.Agents Chemother. 45:367-368. 
 160.  Moritz, E. M. and P. J. Hergenrother. 2007. Toxin−antitoxin systems are ubiquitous 
and plasmid-encoded in vancomycin-resistant enterococci. Proceedings of the 
National Academy of Sciences 104:311-316. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 65
 161.  Mullany, P., M. Pallen, M. Wilks, J. R. Stephen, and S. Tabaqchali. 1996. A group 
II intron in a conjugative transposon from the gram-positive bacterium, Clostridium 
difficile. Gene 174:145-150.  
 162.  Mundy, L. M., D. F. Sahm, and M. Gilmore. 2000. Relationships between 
Enterococcal Virulence and Antimicrobial Resistance. Clin.Microbiol.Rev. 13:513-
522. 
 163.  Murray B, P. R., E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller. 
2007. Streptococcus, p. 412-429. In: P. R. Murray (ed.), Manual of clinical 
microbiology. 9th ed., vol. 1. ASM press, 1752 N St. NW, washington DC. 
 164.  Murray, B. E. 1990. The life and times of the Enterococcus. Clin.Microbiol.Rev. 
3:46-65. 
 165.  Murray, B. E. 1998. Diversity among multidrug-resistant enterococci. 
Emerg.Infect.Dis. 4:37-47. 
 166.  Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock. 
1990. Comparison of genomic DNAs of different enterococcal isolates using 
restriction endonucleases with infrequent recognition sites. J.Clin.Microbiol. 28:2059-
2063. 
 167.  Musser, J. M. and V. Kapur. 1992. Clonal analysis of methicillin-resistant 
Staphylococcus aureus strains from intercontinental sources: association of the mec 
gene with divergent phylogenetic lineages implies dissemination by horizontal transfer 
and recombination. J Clin.Microbiol. 30:2058-2063. 
 168.  Mutschler, H., J. Reinstein, and A. Meinhart. 2010. Assembly dynamics and 
stability of the Pneumococcal epsilon zeta Antitoxin Toxin (PezAT) system from 
Streptococcus pneumoniae. J.Biol.Chem.  
 169.  Nallapareddy, S. R., K. V. Singh, and B. E. Murray. 2008. Contribution of the 
collagen adhesin Acm to pathogenesis of Enterococcus faecium in experimental 
endocarditis. Infect.Immun. 76:4120-4128.  
 170.  Nallapareddy, S. R., K. V. Singh, P. C. Okhuysen, and B. E. Murray. 2008. A 
functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium 
correlates with the recent success of this emerging nosocomial pathogen. 
Infect.Immun. 76:4110-4119. 
 171.  Nallapareddy, S. R., G. M. Weinstock, and B. E. Murray. 2003. Clinical isolates of 
Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a 
new member of the MSCRAMM family. Molecular Microbiology 47:1733-1747.  
 172.  Naser, S., F. L. Thompson, B. Hoste, D. Gevers, K. Vandemeulebroecke, I. 
Cleenwerck, C. C. Thompson, M. Vancanneyt, and J. Swings. 2005. Phylogeny 
and identification of enterococci by atpA gene sequence analysis. J.Clin.Microbiol. 
43:2224-2230. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 66
 173.  Navarre, W. W., M. McClelland, S. J. Libby, and F. C. Fang. 2007. Silencing of 
xenogeneic DNA by H-NS-facilitation of lateral gene transfer in bacteria by a defense 
system that recognizes foreign DNA. Genes Dev. 21:1456-1471.  
 174.  Neely, A. N. and M. P. Maley. 2000. Survival of enterococci and staphylococci on 
hospital fabrics and plastic. J.Clin.Microbiol. 38:724-726. 
 175.  Nigutova, K., I. Styriak, P. Javorsky, and P. Pristas. 2008. Partial characterization 
of Enterococcus faecalis bacteriophage F4. Folia Microbiol.(Praha) 53:234-236. 
 176.  Noto, M. J. and G. L. Archer. 2006. A subset of Staphylococcus aureus strains 
harboring Staphylococcal Cassette Chromosome mec (SCCmec) type IV is deficient in 
CcrAB-mediated SCCmec excision. Antimicrob.Agents Chemother. 50:2782-2788. 
 177.  Okamoto, R., T. Okubo, and M. Inoue. 1996. Detection of genes regulating beta-
lactamase production in Enterococcus faecalis and Staphylococcus aureus. 
Antimicrob.Agents Chemother. 40:2550-2554. 
 178.  Ozawa, Y., E. H. D. Boever, and D. B. Clewell. 2005. Enterococcus faecalis sex 
pheromone plasmid pAM373:: Analyses of TraA and evidence for its interaction with 
RpoB. Plasmid 54:57-69.  
 179.  Palmer, K. L., K. Carniol, J. M. Manson, D. Heiman, T. Shea, S. Young, Q. Zeng, 
D. Gevers, M. Feldgarden, B. Birren, and M. S. Gilmore. 2010. High-quality draft 
genome sequences of 28 Enterococcus sp. isolates. J.Bacteriol. 192:2469-2470. 
 180.  Paulsen, I. T., L. Banerjei, G. S. A. Myers, K. E. Nelson, R. Seshadri, T. D. Read, 
D. E. Fouts, J. A. Eisen, S. R. Gill, J. F. Heidelberg, H. Tettelin, R. J. Dodson, L. 
Umayam, L. Brinkac, M. Beanan, S. Daugherty, R. T. DeBoy, S. Durkin, J. 
Kolonay, R. Madupu, W. Nelson, J. Vamathevan, B. Tran, J. Upton, T. Hansen, 
J. Shetty, H. Khouri, T. Utterback, D. Radune, K. A. Ketchum, B. A. Dougherty, 
and C. M. Fraser. 2003. Role of Mobile DNA in the Evolution of Vancomycin-
Resistant Enterococcus faecalis. Science 299:2071-2074. 
 181.  Peta, M., E. Carretto, D. Barbarini, A. Zamperoni, L. Carnevale, L. Perversi, M. 
Pagani, M. G. Bonora, R. Fontana, P. Marone, and M. Langer. 2006. Outbreak of 
vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit. 
Clin.Microbiol.Infect. 12:163-169. 
 182.  Porwancher, R., A. Sheth, S. Remphrey, E. Taylor, C. Hinkle, and M. Zervos. 
1997. Epidemiological study of hospital-acquired infection with vancomycin-resistant 
Enterococcus faecium: possible transmission by an electronic ear-probe thermometer. 
Infect.Control Hosp.Epidemiol. 18:771-773. 
 183.  Poyart, C., C. Pierre, G. Quesne, B. Pron, P. Berche, and P. Trieu-Cuot. 1997. 
Emergence of vancomycin resistance in the genus Streptococcus: characterization of a 
vanB transferable determinant in Streptococcus bovis. Antimicrob.Agents Chemother. 
41:24-29. 
 184.  Poyart, C., G. Quesnes, and P. Trieu-Cuot. 2000. Sequencing the gene encoding 
manganese-dependent superoxide dismutase for rapid species identification of 
enterococci. J Clin.Microbiol. 38:415-418. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 67
 185.  Quintiliani, J. and P. Courvalin. 1994. Conjugal transfer of the vancomycin 
resistance determinant vanB between enterococci involves the movement of large 
genetic elements from chromosome to chromosome. FEMS Microbiology Letters 
119:359-363.  
 186.  Quintiliani, R. and P. Courvalin. 1996. Characterization of Tn1547, a composite 
transposon flanked by the IS16 and IS256-like elements, that confers vancomycin 
resistance in Enterococcus faecalis BM4281. Gene 172:1-8.  
 187.  Rice, L. B., V. Laktikova, L. L. Carias, S. Rudin, R. Hutton, and S. H. Marshall. 
2009. Transferable capacity for gastrointestinal colonization in Enterococcus faecium 
in a mouse model. The Journal of Infectious Diseases 199:342-349. 
 188.  Rice, L. B. 2001. Emergence of vancomycin-resistant enterococci. Emerg.Infect.Dis. 
7:183-187. 
 189.  Rice, L. B. 2002. Association of different mobile elements to generate novel 
integrative elements. Cell Mol.Life Sci. 59:2023-2032. 
 190.  Rice, L. B., L. Carias, S. Rudin, C. Vael, H. Goossens, C. Konstabel, I. Klare, S. 
R. Nallapareddy, W. Huang, and B. E. Murray. 2003. A potential virulence gene, 
hylEfm, predominates in Enterococcus faecium of clinical origin. J.Infect.Dis. 
187:508-512. 
 191.  Rice, L. B. and L. L. Carias. 1998. Transfer of Tn5385, a composite, multiresistance 
chromosomal element from Enterococcus faecalis. J.Bacteriol. 180:714-721. 
 192.  Rice, L. B., L. L. Carias, and S. H. Marshall. 1995. Tn5384, a composite 
enterococcal mobile element conferring resistance to erythromycin and gentamicin 
whose ends are directly repeated copies of IS256. Antimicrob.Agents Chemother. 
39:1147-1153. 
 193.  Roberts, A. P., M. Chandler, P. Courvalin, G. Guedon, P. Mullany, T. Pembroke, 
J. I. Rood, C. J. Smith, A. O. Summers, M. Tsuda, and D. E. Berg. 2008. Revised 
nomenclature for transposable genetic elements. Plasmid 60:167-173. 
 194.  Roberts, A. P. and P. Mullany. 2006. Genetic basis of horizontal gene transfer 
among oral bacteria. Periodontol.2000. 42:36-46. 
 195.  Rosvoll, T. C., T. Pedersen, H. Sletvold, P. J. Johnsen, J. E. Sollid, G. S. 
Simonsen, L. B. Jensen, K. M. Nielsen, and A. Sundsfjord. 2009. PCR-based 
plasmid typing in Enterococcus faecium strains reveals widely distributed pRE25-, 
pRUM-, pI. FEMS Immunol.Med.Microbiol.58:254-268 
 196.  Rowe-Magnus, D. A. and D. Mazel. 1999. Resistance gene capture. Current Opinion 
in Microbiology 2:483-488.. 
 197.  Ruiz-Garbajosa, P., M. J. M. Bonten, D. A. Robinson, J. Top, S. R. Nallapareddy, 
C. Torres, T. M. Coque, R. Canton, F. Baquero, B. E. Murray, R. del Campo, 
and R. J. L. Willems. 2006. Multilocus sequence typing scheme for Enterococcus 
faecalis reveals hospital-adapted genetic complexes in a background of high rates of 
recombination. J.Clin.Microbiol. 44:2220-2228. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 68
 198.  Salyers, A. A. 1993. Gene transfer in the mammalian intestinal tract. Current Opinion 
in Biotechnology 4:294-298.  
 199.  Sava, I. G., E. Heikens, and J. Huebner. 2010. Pathogenesis and immunity in 
enterococcal infections. Clin.Microbiol.Infect.16:533-540 
 200.  Schouten, M. A., R. J. L. Willems, W. A. G. Kraak, J. Top, J. A. A. Hoogkamp-
Korstanje, and A. Voss. 2001. Molecular analysis of Tn1546-like elements in 
vancomycin-resistant enterococci isolated from patients in Europe shows geographic 
transposon type clustering. Antimicrob.Agents Chemother. 45:986-989. 
 201.  Seville, L. A., A. J. Patterson, K. P. Scott, P. Mullany, M. A. Quail, J. Parkhill, D. 
Ready, M. Wilson, D. Spratt, and A. P. Roberts. 2009. Distribution of tetracycline 
and erythromycin resistance genes among human oral and fecal metagenomic DNA. 
Microb.Drug Resist. 15:159-166. 
 202.  Sillanpää, J., S. R. Nallapareddy, J. Houston, V. K. Ganesh, A. Bourgogne, K. V. 
Singh, B. E. Murray, and M. Hook. 2009. A family of fibrinogen-binding 
MSCRAMMs from Enterococcus faecalis. Microbiology 155:2390-2400.  
 203.  Sillanpaa, J., S. R. Nallapareddy, V. P. Prakash, X. Qin, M. Hook, G. M. 
Weinstock, and B. E. Murray. 2008. Identification and phenotypic characterization 
of a second collagen adhesin, Scm, and genome-based identification and analysis of 
13 other predicted MSCRAMMs, including four distinct pilus loci, in Enterococcus 
faecium. Microbiology 154:3199-3211.  
 204.  Sillanpaa, J., V. P. Prakash, S. R. Nallapareddy, and B. E. Murray. 2009. 
Distribution of genes encoding MSCRAMMs and Pili in clinical and natural 
populations of Enterococcus faecium. J.Clin.Microbiol. 47:896-901.  
 205.  Solomon, J. M. and A. D. Grossman. 1996. Who's competent and when: regulation 
of natural genetic competence in bacteria. Trends in Genetics 12:150-155.  
 206.  Sorensen, S. J., M. Bailey, L. H. Hansen, N. Kroer, and S. Wuertz. 2005. Studying 
plasmid horizontal transfer in situ: a critical review. Nat Rev Micro 3:700-710. 
doi:10.1038/nrmicro1232. 
 207.  Stampone, L., G. M. Del, D. Boccia, and A. Pantosti. 2005. Clonal spread of a 
vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting 
isolates in Italy. J Clin.Microbiol. 43:1575-1580. 
 208.  Stellwagen, A. E. and N. L. Craig. 1997. Avoiding self: two Tn7-encoded proteins 
mediate target immunity in Tn7 transposition. EMBO J 16:6823-6834. 
 209.  Stiles, M. E., N. W. Ramji, L. K. Ng, and D. C. Paradis. 1978. Incidence and 
relationship of group D streptococci with other indicator organisms in meats. Can.J 
Microbiol. 24:1502-1508. 
 210.  Summers, A. O. 2006. Genetic linkage and horizontal gene transfer, the roots of the 
antibiotic multi-resistance problem. Animal Biotechnology 17:125-135. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 69
 211.  Sun, J., X. Song, B. E. Kristiansen, A. Kjaereng, R. J. L. Willems, H. M. Eriksen, 
A. Sundsfjord, and J. E. Sollid. 2009. Occurrence, population structure, and 
antimicrobial resistance of enterococci in marginal and apical periodontitis. 
J.Clin.Microbiol. 47:2218-2225. 
 212.  Suzuki, E., K. Kuwahara-Arai, J. F. Richardson, and K. Hiramatsu. 1993. 
Distribution of mec regulator genes in methicillin-resistant Staphylococcus clinical 
strains. Antimicrob.Agents Chemother. 37:1219-1226. 
 213.  Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. 
Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction 
patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain 
typing. J Clin.Microbiol. 33:2233-2239. 
 214.  Thiercelin.M.E. 1899. Morphologie et modes des de reproduction de l'enterocoque. 
Compt.rend.soc.biol 51:55. 
 215.  Thomas, C. M. and K. M. Nielsen. 2005. Mechanisms of, and barriers to, horizontal 
gene transfer between bacteria. Nat Rev Microbiol. 3:711-721. 
 216.  Top, J., R. Willems, S. van der Velden, M. Asbroek, and M. Bonten. 2008. 
Emergence of Clonal Complex 17 Enterococcus faecium in The Netherlands. 
J.Clin.Microbiol. 46:214-219. 
 217.  Top, J., R. Willems, and M. Bonten. 2008. Emergence of CC17 Enterococcus 
faecium: from commensal to hospital-adapted pathogen. FEMS 
Immunol.Med.Microbiol. 52:297-308. 
 218.  Torell, E., O. Cars, B. Olsson-Liljequist, B. M. Hoffman, J. Lindback, L. G. 
Burman, and The Enterococcal Study Group. 1999. Near absence of vancomycin-
resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant 
enterococci among hospitalized patients and nonhospitalized individuals in Sweden. 
J.Clin.Microbiol. 37:3509-3513. 
 219.  Treitman, A. N., P. R. Yarnold, J. Warren, and G. A. Noskin. 2005. Emerging 
incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J 
Clin.Microbiol. 43:462-463. 
 220.  Tsubakishita, S., K. Kuwahara-Arai, T. Baba, and K. Hiramatsu. 2010. 
Staphylococcal cassette chromosome mec-like element in Macrococcus caseolyticus. 
Antimicrob.Agents Chemother. 54:1469-1475.  
 221.  Tsvetkova, K., J. C. Marvaud, and T. Lambert. 2010. Analysis of the mobilization 
functions of the vancomycin resistance transposon Tn1549, a member of a new family 
of conjugative elements. J.Bacteriol. 192:702-713.  
 222.  Turner, K. M., W. P. Hanage, C. Fraser, T. R. Connor, and B. G. Spratt. 2007. 
Assessing the reliability of eBURST using simulated populations with known 
ancestry. BMC.Microbiol. 7:30. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 70
 223.  Umeda, A., F. Garnier, P. Courvalin, and M. Galimand. 2002. Association 
between the vanB2 glycopeptide resistance operon and Tn1549 in enterococci from 
France. J.Antimicrob.Chemother. 50:253-256. 
 224.  Uttley, A. H., C. H. Collins, J. Naidoo, and R. C. George. 1988. Vancomycin-
resistant enterococci. Lancet 1:57-58. 
 225.  Valdezate, S., C. Labayru, A. Navarro, M. A. Mantecon, M. Ortega, T. M. 
Coque, M. Garcia, and J. A. Saez-Nieto. 2009. Large clonal outbreak of multidrug-
resistant CC17 ST17 Enterococcus faecium containing Tn5382 in a Spanish hospital. J 
Antimicrob.Chemother. 63:17-20. 
 226.  van den Braak, N., E. Power, R. Anthony, H. P. Endtz, H. A. Verbrugh, and A. 
van Belkum. 2000. Random amplification of polymorphic DNA versus pulsed field 
gel electrophoresis of SmaI DNA macrorestriction fragments for typing strains of 
vancomycin-resistant enterococci. FEMS Microbiol.Lett. 192:45-52. 
 227.  van der Ploeg, J. R. 2008. Characterization of Streptococcus gordonii prophage 
PH15: complete genome sequence and functional analysis of phage-encoded integrase 
and endolysin. Microbiology 154:2970-2978. 
 228.  van Schaik, W. and R. J. Willems. 2010. Genome-based insights into the evolution 
of enterococci. Clin.Microbiol.Infect. 
 229.  van Schaik, W., J. Top, D. Riley, J. Boekhorst, J. Vrijenhoek, C. Schapendonk, 
A. Hendrickx, I. Nijman, M. Bonten, H. Tettelin, and R. Willems. 2010. 
Pyrosequencing-based comparative genome analysis of the nosocomial pathogen 
Enterococcus faecium and identification of a large transferable pathogenicity island. 
BMC Genomics 11:239.  
 230.  Villion, M., M. C. Chopin, H. Deveau, S. D. Ehrlich, S. Moineau, and A. Chopin. 
2009. P087, a lactococcal phage with a morphogenesis module similar to an 
Enterococcus faecalis prophage. Virology 388:49-56. 
 231.  Waksman, S. A. and H. B. Woodruff. 1940. The soil as a source of microorganisms 
antagonistic to disease-producing bacteria. J.Bacteriol. 40:581-600. 
 232.  Wang, L. and G. L. Archer. 2010. Roles of CcrA and CcrB in the excision and 
integration of SCCmec, a Staphylococcus aureus genomic island. J.Bacteriol.JB. 
 233.  Weigel, L. M., D. B. Clewell, S. R. Gill, N. C. Clark, L. K. McDougal, S. E. 
Flannagan, J. F. Kolonay, J. Shetty, G. E. Killgore, and F. C. Tenover. 2003. 
Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus 
aureus. Science 302:1569-1571. 
 234.  Werner, G., T. M. Coque, A. M. Hammerum, R. Hope, W. Hryniewicz, A. 
Johnson, I. Klare, K. G. Kristinsson, R. Leclercq, C. H. Lester, M. Lillie, C. 
Novais, B. Olsson-Liljequist, L. V. Peixe, E. Sadowy, G. S. Simonsen, J. Top, J. 
Vuopio-Varkila, R. J. Willems, W. Witte, and N. Woodford. 2008. Emergence and 
spread of vancomycin resistance among enterococci in Europe. Euro.Surveill 13. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 71
 235.  Werner, G., C. Fleige, B. Ewert, J. A. Laverde-Gomez, I. Klare, and W. Witte. 
2010. High-level ciprofloxacin resistance among hospital-adapted Enterococcus 
faecium (CC17). Int.J.Antimicrob.Agents 35:119-125.. 
 236.  Werner, G., I. Klare, F. B. Spencker, and W. Witte. 2003. Intra-hospital 
dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus 
faecium in a paediatric ward of a German hospital. J Antimicrob.Chemother. 52:113-
115. 
 237.  Werner, G., B. Strommenger, and W. Witte. 2008. Acquired vancomycin resistance 
in clinically relevant pathogens. Future.Microbiol. 3:547-562. 
 238.  Wicker, T., E. Schlagenhauf, A. Graner, T. J. Close, B. Keller, and N. Stein. 2006. 
454 sequencing put to the test using the complex genome of barley. BMC.Genomics 
7:275.  
 239.  Willems, R. J. and M. J. Bonten. 2007. Glycopeptide-resistant enterococci: 
deciphering virulence, resistance and epidemicity. Curr.Opin.Infect.Dis. 20:384-390. 
 240.  Willems, R. J., J. Top, S. M. van, D. A. Robinson, T. M. Coque, F. Baquero, H. 
Grundmann, and M. J. Bonten. 2005. Global spread of vancomycin-resistant 
Enterococcus faecium from distinct nosocomial genetic complex. Emerg.Infect.Dis. 
11:821-828. 
 241.  Willems, R. J. and W. van Schaik. 2009. Transition of Enterococcus faecium from 
commensal organism to nosocomial pathogen. Future.Microbiol. 4:1125-1135.  
 242.  Williams, K. P. 2002. Integration sites for genetic elements in prokaryotic tRNA and 
tmRNA genes: sublocation preference of integrase subfamilies. Nucleic Acids Res. 
30:866-875. 
 243.  Wozniak, R. A., D. E. Fouts, M. Spagnoletti, M. M. Colombo, D. Ceccarelli, G. 
Garriss, C. Dery, V. Burrus, and M. K. Waldor. 2009. Comparative ICE genomics: 
insights into the evolution of the SXT/R391 family of ICEs. PLoS.Genet. 5:e1000786.  
 244.  Wozniak, R. A. and M. K. Waldor. 2009. A toxin-antitoxin system promotes the 
maintenance of an integrative conjugative element. PLoS.Genet. 5:e1000439.  
 245.  Wright, G. D. 2007. The antibiotic resistome: the nexus of chemical and genetic 
diversity. Nat Rev Micro 5:175-186.  
 246.  Xu.X, Lin.D, Guo.Y, Wu.S, Ye.X, Zhu.D, and Wang.M. vanM gene cluster - a new 
glycopeptide resistence gene cluster in a clinical isolate of Enterococcus faecium. 20th 
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).  
2010. 11-4-2010.  
 
 247.  Yasmin, A., J. G. Kenny, J. Shankar, A. C. Darby, N. Hall, C. Edwards, and M. 
J. Horsburgh. 2010. Comparative genomics and transduction potential of 
Enterococcus faecalis temperate bacteriophages. J.Bacteriol. 192:1122-1130. 
Ph.D Thesis, 2010  Bjørkeng, EK. 
 72
 248.  Young, H. L., S. A. Ballard, P. Roffey, and M. L. Grayson. 2007. Direct detection 
of vanB2 using the Roche LightCycler vanA/B detection assay to indicate 
vancomycin-resistant enterococcal carriage sensitive but not specific. 
J.Antimicrob.Chemother. 59:809-810.  
 249.  Zhang, K., J. A. McClure, S. Elsayed, and J. M. Conly. 2009. Novel staphylococcal 
cassette chromosome mec type, tentatively designated type VIII, harboring class A 
mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-
resistant Staphylococcus aureus. Antimicrob.Agents Chemother. 53:531-540. 
 250.  Zheng, B., H. Tomita, T. Inoue, and Y. Ike. 2009. Isolation of VanB-type 
Enterococcus faecalis strains from nosocomial infections: First report of the isolation 
and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-
type vancomycin resistance and a Bac41-type bacteriocin, and pMG2201, encoding 
erythromycin resistance and cytolysin (Hly/Bac). Antimicrob.Agents Chemother. 
53:735-747. 
 
 
 
 
 
 
Paper I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paper II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paper III 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN 978-82-7589-277-3 
 
 
 
